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Abstract 
FLEXcon has developed novel electrocardiogram electrodes that use a dry interface that does not 
dehydrate over time, in contrast to the current industry standard Ag/AgCl hydrogel electrodes 
which require dehydration barriers in packaging and dry out over a few days. The optimized 
carbon to pressure sensitive adhesive concentration for the minimum material impedance is 10% 
carbon to 90% PSA. The carbon based dry electrodes require activation to lower their impedance 
below the AAMI defibrillation overload standards. Using a defibrillation overload circuit, which 
applies electrophoresis to the electrodes, the parameters which give the lowest impedance are 
200 V, 100 mA, and a 100 ms discharge time across the electrode. Acquiring electrocardiogram 
signals from ten subjects, using the FLEXcon electrodes and hydrogel electrodes simultaneously, 
resulted in 66 minutes of data for analysis. Signal processing of this data showed that, from three 
FLEXcon electrodes of different sizes, the large electrode had the greatest signal fidelity when 
compared to the hydrogel electrodes. This study concludes that the 10% carbon concentration 
electrodes, at the largest size given by FLEXcon for testing, are able to substitute the hydrogel 
Ag/AgCl electrodes in a clinical setting. 
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Executive Summary 
The company FLEXcon has designed novel alternative signal receptive media (SRM) 
electrodes to record ECG signals.  The standard electrodes currently available on the market are 
Silver/Silver Chloride (Ag/AgCl).  The overall goal of this project was to optimize FLEXcon’s 
electrodes and compare the signal quality to that of Ag/AgCl electrodes.  Lowering post 
activation impedance of the electrodes was also a key goal of this project. A lower impedance 
results in higher signal strength in the recording of the ECG signal.  The team had four objectives 
in order to achieve the project goal.   
The first objective was to find the optimum mixture for the electrodes.  To do this, the 
team needed to find the optimal percentage of carbon in the carbon-PSA mixture by changing the 
percentage of carbon from 2-12% in increments of two, and determine which mixture resulted in 
the lowest post-activation impedance.  Second, the investigators had to determine the optimal 
electrode activation parameters.  An activation circuit with variable parameters was built based 
on industry standards set by the Association for the Advancement of Medical Instrumentation 
(AAMI), and used a capacitive discharge to cause electrophoresis to occur in these dry carbon 
based electrodes.  The third objective was to simultaneously record ECG using FLEXcon’s 
electrodes as well as Ag/AgCl electrodes on human subjects by using multichannel Holter 
monitors that are capable of recording ECG from two sets of electrodes. The final objective was 
processing the signals acquired from the human subjects using MATLAB.  This analysis allowed 
for the comparison of FLEXcon’s novel electrodes to the conventional Ag/AgCl electrodes. 
After fabricating and testing electrodes of varying carbon concentrations, it was 
determined that the best mixture for electrodes was 10% carbon and 90% pressure sensitive 
adhesive (PSA).  This type of electrode was fabricated and used for the rest of the project.  To 
satisfy the second objective presented to the group, a defibrillation overload circuit was designed 
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and implemented to test for various activation parameters. It was found that an activation voltage 
of 200 V along with activation amperage of 100 mA with a 100 ms capacitor discharge time 
optimized the post-activation impedance. These parameters resulted in a mean post-activation 
impedance of 875 Ω with a standard deviation of 657 Ω. The AAMI requirement is that the mean 
post-activation impedance be less than 2 kΩ with no single electrode impedance exceeding 3 kΩ.  
To compare the signal quality of FLEXcon and Ag/AgCl electrodes, both electrodes were 
used to record ECG simultaneously in 10 human subjects, with six minutes of data collected per 
subject.  Three different sizes of FLEXcon electrodes were fabricated and compared against the 
industry gold standard to determine the optimal electrode size.  Both time and frequency domain 
analyses were performed on the collected data.  A bandpass filter between 5-11 Hz was used to 
clean the data collected from both electrode channels, and using MATLAB, the team scripted a 
peak detection algorithm to locate the R segment of the QRS complex of the ECG waveform. 
Further analysis included heart rate calculation (beats per minute), RMSSD comparison for 
electrode variability, RMSSD t-tests, and power spectral density plots.  The peak detection 
graphs from both FLEXcon and Ag/AgCl electrodes showed negligible morphological 
differences.  
Data analysis showed that FLEXcon’s large electrode size (5 cm X 4 cm) was by far the 
most comparable to Ag/AgCl electrodes.  The mean heart rate from all the subjects in the Holter 
monitor study was 73.9 ± 9.60 bpm for the large electrodes, and the mean of the corresponding 
Ag/AgCl electrodes was 73.9 ± 9.77 bpm.  Paired sample t-tests were performed to contrast 
between the two electrodes, and no statistically significant differences were discovered between 
FLEXcon’s electrodes and the industry standard Ag/AgCl electrodes.    
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In conclusion, this project verified that the novel Signal Receptive Media (SRM) 
invented at FLEXcon can be used to fabricate dry ECG electrodes. These electrodes require to be 
activated by a capacitive discharge, but a key strength they possess in comparison to the industry 
gold standard is that they do not require special packaging to prevent dehydration. Moreover, 
they have a significantly longer shelf life, and can be produced at a cheaper cost than Ag/AgCl 
electrodes. As a result, since the Holter Monitor study proved that the signal acquired by these 
novel electrodes are morphologically and statistically similar to the signal obtained by Ag/AgCl 
electrodes, they can potentially replace them as the industry gold standard in the future.  
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1. Introduction 
 Electrocardiography (ECG) is a graphical interpretation of the electrical activity of the 
heart, and to properly monitor the cardiac health of a patient, it is crucial to obtain an ECG signal 
with a low Signal-to-Noise Ratio (SNR). In a typical ECG setup, depending on the particular 
application, three to twelve signal receptive electrodes are attached to the patient’s body. These 
electrodes are able to pick up the minute changes in potential that occur as a consequence of the 
propagation of the cardiac vector during the timeframe of a single heartbeat, thus rendering it 
possible to produce the characteristic ECG waveform that can then be used for diagnostic 
purposes. To ensure optimal signal strength, it is prudent to minimize the impedance of the skin-
electrode interface by lowering the impedance of the electrode used. High impedance levels at 
the skin-electrode interface can result in significant losses in signal strength and low SNR, which 
can render the obtained signal difficult to process. 
 The current industry gold standard for ECG electrodes is the Silver/Silver Chloride 
hydrogel electrodes. These electrodes consist of a layer of silver chloride, often in the form of a 
paste-like hydrogel surrounding a silver disc. While the hydrogel layer significantly improves the 
signal quality by effectively lowering the impedance that exists at the skin-electrode interface, it 
is also the principal reason behind the relatively short shelf life of these electrodes. The hydrogel 
layer that exists in the skin-electrode interface diminishes with time as it dehydrates. This leads 
to a loss of signal quality and an increased incidence of motion artifacts in the ECG. Moreover, 
this also means that the electrodes need to be carefully packaged to ensure optimal retention of 
the hydrogel layer.  
FLEXcon USA© has attempted to address the issue of dehydration that is prevalent in the 
current industry gold standard electrodes by designing a novel signal receptive media that does 
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not require a hydrogel layer. These electrodes are designed by combining a patented Pressure 
Sensitive Adhesive (PSA) with carbon black. After the electrodes are fabricated, the electrodes 
need to be activated by electrophoresis to ensure that they meet the Association for the 
Advancement of Medical Instrumentation (AAMI) requirement for defibrillation overload. 
AAMI states that for dry, non-hydrogel based electrodes such as FLEXcon electrodes, the 
average post-activation impedance must remain below 2 kΩ, and no single electrode could have 
impedance equal to or greater than 3 kΩ after activation.  
To ensure that FLEXcon electrodes met the AAMI standard for dry electrodes, the group 
designed and implemented an activation circuit which was capable of providing various levels of 
activation voltage, amperage with varying discharge times. This allowed the group to obtain the 
best parameters required for the activation. The group also needed to discern the optimal 
concentration of carbon in the electrodes, as well as the optimal size of the electrodes. Once the 
activation parameters as well as the concentration of carbon were determined, the group moved 
on to a Holter monitor study contrasting the FLEXcon electrodes with the industry gold standard 
to ascertain if FLEXcon’s design could potentially be as receptive to ECG signals as Ag/AgCl 
electrodes. Simultaneous acquisition of ECG was done using the two electrode types on 10 
subjects, and six minutes of data was collected from each subject.  
After data collection, the team used the algorithm outlined in “A Real-Time QRS 
Detection Algorithm” by Pan and Tomkins and implemented it in MATLAB to perform peak 
detection on data collected from Ag/AgCl electrodes as well as FLEXcon electrodes. This was 
followed by various statistical analysis steps to contrast between the two types of electrodes. It 
was discovered that FLEXcon’s novel ECG electrodes were directly comparable to the industry 
gold standard pending further development. 
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2. Client Statement 
The following "Client Statement" was proposed by the FLEXcon MQP group on October 2nd, 
2012: 
 
"FLEXcon has patented an alternative Signal Receptive Media (SRM) to the 
hydrogel currently used in electrocardiogram (ECG) electrodes for heart 
monitoring. During the MQP, students will develop a test method, design of 
experiments (DOE) and evaluate the resultant SRM." 
 
FLEXcon shared its proposal with the FLEXcon MQP group on August 27
th
 2012, identifying 
three stages with a total of six deliverables. 
 
Stage 1: Design an experiment (DOE) with the following input variables:  
 
  a. % carbon loading (or blend if two carbon dispersions are available) 
  b. PSA (V-95 vs. V-95 with low crosslinker) 
  c. Activation Voltage 
  d. Activation Amperage 
  e. Activation Time* 
 
The response variable for both experiments will be Impedance as measured by a test method 
designed by the students. These results are to be reported directly to FLEXcon. 
 
 
 
*Note: Activation time should be fixed for the initial DOE. Once an optimized formula is identified, design and conduct a second experiment 
with variable activation duration. Target will be less than 0.5 sec to allow efficient manufacturing. 
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Stage 2: Develop a test protocol to compare signal quality of optimized SRM to Hydrogel. This 
should include consideration for resistance to noise and interference (e.g. 60Hz, muscle artifacts, 
etc.). 
 
Stage 3: Evaluate the top 2 or 3 SRM designs compared to industry leading hydrogel electrodes 
using the test method from Stage 2. 
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3. Literature Review 
Electrocardiogram 
The Electrocardiogram, commonly known as ECG or EKG, is a graphical representation 
of the electrical activity of the heart. Currently, it is usually recorded via Silver-Silver Chloride 
(Ag-AgCl) electrodes that require a hydrostatic gel to adhere to the patient’s chest. Typically, 
three or more electrodes are used to record various waves that are generated as a result of the 
heart’s electrical activity. The ECG can then be utilized by medical professionals to compute the 
heart rate and assess the overall health of the heart. 
The term Electrocardiogram was first coined by the Dutch physiologist Willem 
Einthoven (Einthoven, 1893). Using an improved electrometer and a correction formula he 
developed, Einthoven distinguished the five waves P, Q, R, S and T in the ECG. The first string 
galvanometer which was designed by Einthoven to record ECG weighed an incredible 600 
pounds (Brief history of electrocardiography, 2009).  
The sinoatrial node within the heart, also known as the SA node or the heart’s natural 
pacemaker, is located in the right atrium of the heart and initiates the electrical impulse that leads 
to the generation of the normal sinus rhythm. This leads to a rapid depolarization of the right 
atrium, which is picked up as the first half of the P-wave in the ECG. This wave of 
depolarization then spreads to the left atrium of the heart, and is subsequently recorded as the 
second half of the P-wave. The QRS complex follows the P wave, generated from the 
depolarization of the ventricles. The T wave is produced by the repolarization of the ventricles. 
The U wave occasionally follows the T wave as a result of the repolarization of the Bundle of 
His-Purkinje cells. An image of a healthy ECG signal is provided in Fig. 1. 
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Fig. 1: An electrocardiograph (Hurst, 1998) 
The R-R interval between successive ECG signals is used to calculate the heart rate of the patient 
based on the equation 1. 
                      
 
                     
 
QRS wave detection 
 One of the most vital components of an ECG is the QRS complex, characterized by a 
sharply rising peak during ventricular contraction, which corresponds to the depolarization of the 
right and left ventricles of the heart. On the electrocardiogram, the Q wave is a short downward 
deflection from the baseline. It is rapidly followed by a sharp rising peak during the R wave. The 
S wave is characterized as the downward deflection that follows the R wave. For signal analysis 
purposes, the QRS complex is treated as a single component of the ECG and usually lasts as long 
as 60 ms to 100 ms in healthy human adults (Klabunde, 2007). 
 In the absence of any signal processing, the QRS complex may be very difficult to detect. 
Even if the physiological variability in each individual QRS complex in a patient is forgone, the 
presence of numerous noise sources alone can make it challenging for the complex to be 
detected. Some of the common noise sources in QRS detection include muscle noise, electrode 
motion, 60Hz interference from power lines, and baseline wander. Occasionally, T waves with 
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high frequency characteristics can be mistaken for a QRS complex (Pan, 1985). Although the 
QRS complex contains several high frequency components, for peak detection purposes they are 
not as relevant as the frequency band between 5Hz and 11Hz (Pan, 1985).  
 Before any digital signal processing is done, the ECG signal has to pass through an 
analog lowpass filter (LPF) which bandlimits the ECG to under 50Hz (Pan, 1985). This analog 
signal is then sampled and quantized to bring the data into the digital domain. Once that has been 
done, a digital bandpass filter (BPF) begins the signal processing by passing the signal between 
5Hz to 15Hz and attenuating every other frequency bands. It is important to note that for real 
time applications the bandpass filter should be designed with integer coefficients to minimize 
processing time. What this method accomplishes is minimization of DC noise, 60Hz power line 
interference, baseline wander, muscle noise and T wave interference. Due to the relatively low 
amplitude of the QRS complex, which is about 0.7 mV in healthy adults, compared to the power 
line interference, which is a 60Hz signal at 110V, it may be a good idea for some signal 
processing applications to implement a notch filter at 60Hz to further attenuate that noise. 
However, it needs to be noted that any additional signal processing steps add to the computation 
time of the ECG and thus increases the delay, so there is a tradeoff involved regarding signal 
integrity and implementation in real time. 
 The output of the bandpass filter contains less noise, and at this stage the signal is 
differentiated to provide the QRS complex slope information (Pan, 1985). This process must be 
done after the bandpass filter, regardless of the particular application, since taking the derivative 
is often detrimental to the signal-to-noise ratio of the ECG. Once the differentiation has 
completed, the output is squared point by point. This does two things to the signal; (i) it makes 
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all data points in the QRS complex to be analyzed positive numbers, and (ii) it provides a way to 
amplify the output of the derivative in a nonlinear fashion (Pan, 1985).  
 Once the output of the derivative has been squared, it is passed through a moving window 
integrator. Conceptually, what a moving window integrator does is act like a lowpass filter. The 
window takes an empirically determined N samples and averages their values. Ideally, the 
window should be as wide as the largest possible QRS period in the set (Pan, 1985). By doing 
this, the errors introduced by baseline wander in the data can be reduced. The effect of baseline 
wander can be reduced even further by setting two adjustable thresholds that detect a QRS 
complex peak and updates based on the past values of the samples periodically. Fig. 2. 
demonstrates the output from each of these signal processing steps. 
 
Fig. 2: QRS detection algorithm processing steps 
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History of Electrocardiogram 
The origin of the ECG, an important diagnostic medical tool, dates back to the late nineteenth 
century.  In 1869, Alexander Muirhead, an electrical engineer who did not publish his studies, 
attached an ink siphon to a moving coil galvanometer.  This sprayed ink onto a moving piece of 
paper.  The first record of a clinical electrocardiogram is from 1887, when Augustus Desire 
Waller was able to continuously record on photosensitive paper.  He did this using a capillary 
electrometer.  He found that the position changes of the meniscus in the capillary electrometer 
paralleled current changes, and was able to demonstrate this using his dog as a specimen.  
Willem Einthoven, a respiratory physiology researcher, saw this demonstration and continued 
Waller’s work.  He wanted more accurate measurements, so he improved the resolution and 
modified Waller’s technology to produce higher quality readings (Ball, Mar 2010.).    
Einthoven used a string galvanometer for his work, shown in Fig. 3. This system contained a 
quartz filament that passed between two electromagnets.  Any current that went through the 
filament resulted in the movement that was projected and recorded, corresponding to the current 
changes.  In order to improve the response time and sensitivity of the recording, Einthoven used 
fine quartz string filament, and published his first electrocardiogram in 1902 (Ball, Mar 2010.). 
 
Fig. 3: Einthoven’s "string galvanometer" used for his electrocardiogram work (Ball, 2010) 
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Einthoven continued his work by applying a correction formula to the readings so that they 
were more accurate, and named the waves in the recording the P, Q, R, S, and T waves.  In 1912, 
Einthoven introduced what is now referred to as “Einthoven’s Triangle,” or vector 
electrocardiography using three leads to form an equilateral triangle. The term “lead” is used to 
represent a pair of reference electrodes which together gives a trace of the potential difference 
between the said electrode pair. In order to record the patient’s ECG, the arms and one leg of the 
subject were immersed in saline solution (Ball, Mar 2010.).  Einthoven’s Triangle can be seen in 
Fig. 4. 
 
Fig. 4: Einthoven's Triangle, which uses three leads to form a triangle (Normal Vectors) 
 Due to the large size of the galvanometer that Einthoven was using for his work, the size 
of the device needed to be reduced before it could be used on a regular basis in a clinical setting 
(Ball, Mar 2010.).  In 1934, Frank Wilson discovered that he could join the lead wires from the 
arms and leg with a 5kΩ resistor, resulting in a combined lead which he attached to the negative 
ECG terminal.  Then, he could connect an electrode to the positive terminal, and because of the 
other connection to the negative terminal, this electrode would be unipolar. Thus, it could be 
placed anywhere on the body (Jenkins, 2009.) .  
Further progression of the ECG took place in 1938, when the American Heart Association, 
along with the Cardiac Society of Great Britain, defined the standard positioning and wiring of 
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the six chest leads used for the ECG.  In 1942, Emanuel Goldberger experimented with the 
voltage that Wilson’s unipolar electrode used, and increased it by 50%.  This resulted in the 
creation of the augmented limb leads, aVR, aVL, and aVF, which, combined with Einthoven’s 
triangle and the six chest leads, result in the 12-lead ECG that is currently used (Kilpatrick, 
1994). 
Biopotential Electrodes 
Biopotential recordings can come in the form of ECG, Electroencephalography (EEG), 
Electrooculography (EOG) and Electromyography (EMG), which are vital for detection and 
treatment in patients; they can also provide research opportunities. There has been an increase in 
interest in wireless mobile systems based on the healthcare industry. A key area is developing 
alternative biopotential electrodes for patient physiological monitoring. Currently there exist two 
types, which are in trial. One electrode is a conventional wet adhesive Ag-AgCl, which provides 
an excellent signal, however is irritating and bulky for mobile uses. The other type of electrode 
comes in two forms, which are dry and non-contact. They operate without the need for a wet gel 
adhesive; however they have not gained acceptance for medical uses from the FDA at the present 
time. 
 Dry electrodes address the comfort issues that patients frequently mention, but are more 
difficult to secure on the patient, which makes them less likely to replace the standard ECG and 
EEG wet gel electrodes used in hospitals. They lack the advantage of a conductive gel, which are 
more sensitive to the condition of the skin and are highly susceptible to motion artifacts. Because 
they are dry, the method of sufficient adhesion to the skin is contributed by sweat, which counter 
acts the increased skin-electrode impedance and makes it almost comparable to that of wet 
electrodes after a few minutes of sweat build up. 
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Non-contact electrodes on the other hand require no resistive connection to the body; 
they have the advantage of being insensitive to skin conditions and can be embedded within 
clothes for monitoring of patients, while at home or other locations outside the medical setting.  
 Clinical trials have shown that even though there was a sufficient deal of noise in the 
signal picked up from non-contact electrodes, due to impedance from cotton which was the 
medium used for testing, the increased noise did not prevent the detection of an acceptable ECG 
measurement. The dry electrodes performed equally as well.  With this capability of being able 
to continuously record an biopotential signal without direct contact with the skin opens the doors 
to the future, because as stated this enable long term clinical home diagnosis and care 
applications. 
Silver chloride electrodes used in traditional ECG 
An ECG electrode is commonly composed of a small metal plate surrounded by an 
adhesive pad, which is coated with a conducting gel to aid transmission of the signal. The novel 
ECG electrodes developed at FLEXcon are quite different from these traditional electrodes. The 
Pressure Sensitive Adhesive (PSA) used in the novel ECG electrodes results in a more durable 
electrode. In traditional electrodes, the durability is severely limited due to the electrolytic gel 
drying up too fast. The novel ECG electrodes use activated carbon as a method of transferring 
electrical impulses in place of the gel, which leads to a greater lifetime. This difference in 
longevity between the two electrodes can be confirmed as part of this Major Qualifying Project. 
The silver chloride reference electrode is widely used in various industrial applications 
such as the process of recording ECG. It is inexpensive and non-toxic. These qualities therefore 
make silver chloride electrodes a decent choice of electrodes to be used in a medical setting.  A 
silver chloride electrode consists of a hollow plastic tube electrode body. The conducting part of 
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the electrode is made of a silver wire which is usually coated with a thin layer of silver chloride. 
A porous plug on one end maintains contact with the surface of the patient’s skin, and the silver 
conductor is bathed in a chloride solution (Sief Otten, 1998). Silver chloride has a very low 
solubility in water and forms a white precipitate (AUS-e-TUTE). Due to this, a separate 
conductive gel is also applied between the silver plate end of the electrode and the patient’s skin 
to maintain a pathway for current to pass through (Townsend, 2001). Usually, the solution 
consists of a dissolved chloride salt such as potassium chloride in strong concentrations to avoid 
disintegrating the silver chloride from the silver wire (Roberge, 2012). Some of the silver from 
the wire may dissolve into the gel to produce silver ions and electrons as shown in equation 2: 
                      
 Once attached with a combination of saturated potassium chloride solution, the electrode 
develops a potential of 199mV against the standard hydrogen electrode (Roberge, 2012). At 
equilibrium, this phase boundary potential depends on the chloride ion activity of the electrolyte; 
maintaining a constant chloride ion activity is essential in keeping this potential at a constant 
level. One of the disadvantages of the silver chloride electrode is that silver ions may form 
precipitates such as silver sulfide and silver nitrate and clog the liquid junction of the electrode 
(Webster, 1998). 
 A double layer of Ag
+
 and Cl
-
 ions build up when the electric field set up by the 
dissolving ions is balanced by the concentration gradient (Townsend, 2001). This double layer is 
referred to as the electrode double layer and this can be put in an equivalent circuit model to 
estimate what the electrical behavior of the body-electrode interface will be like. The equivalent 
circuit model of the body-electrode interface is provided in Fig. 5. The values of the various 
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components of the equivalent circuit model depend on the area of the electrode, surface 
condition, current density and the type and concentration of the conductive gel. 
 
Fig. 5: Equivalent circuit of the Ag-AgCl interface (Townsend, 2001) 
 One of the major issues faced with silver chloride electrodes is that they easily introduce 
motion artifacts in the ECG. If the patient is in motion, the distribution of charge at the interface 
can be mechanically disturbed. This leads to the half-cell potential of the body-electrode 
interface to change momentarily until the motion is halted and the Nernst equilibrium is re-
established. If one of the electrodes in a lead experiences motion while the other stays still, an 
unwanted potential difference appears in the lead which may cause severe interference in the 
measurement of ECG (Townsend, 2001). The overall equivalent circuit for a lead is provided in 
Fig. 6. 
 
Fig. 6: Equivalent circuit model of an ECG lead (Townsend, 2001) 
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Hook Effect Artifact 
 In Electrical Bio-Impedance (EBI) spectroscopy measurements, the presence of parasitic 
capacitances creates a measurement error commonly known as the Hook Effect (Buendia, 2010). 
It is named as such because of its characteristic hook-like shape on an impedance plot against 
frequency. At higher frequencies, it is observed that the measured impedance appears to increase 
when it should actually be decreasing at higher frequencies. The hook effect comes into play in 
impedance measurements at high frequencies, because of the lower impedance that appears from 
the parasitic capacitance. This drives away current from the true impedance of the component 
and as a result, the measured impedance is much more than what it is in reality.  
Figure 7. shows the equivalent circuit model that can be used to understand the Hook 
Effect. The presence of the stray capacitance CPAR causes a portion of the current supplied by the 
LCR meter to leak through the stray capacitance. This leads to less current flowing through the 
impedance block that is being analyzed and gives a larger value for the impedance as a result. 
Although the Hook Effect is not as prominent in low frequencies as it is in high frequencies, the 
phenomenon is still observable. 
 
Fig. 7: equivalent circuit model for hook effect observation (Buendia, 2010) 
 Traditionally, the Hook Effect was corrected by the Td compensation method. This 
method involves taking the measured impedance and multiplying it with a complex exponential 
in the form e
jwT
d, where w is the frequency in radians and Td is a scalar factor. There were a few 
problems in using this method. Firstly, since the factor Td is a real, scalar number, raising it in a 
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complex exponential and multiplying the measured impedance with it only changes the phase of 
the measured impedance and not its amplitude. Secondly, this can only be used to fix the 
measured impedance for one particular frequency depending on the value of w that is selected 
(Buendia, 2010). 
 In a new approach to removing the Hook Effect, Buendia replaced the scalar factor Td 
with a corrective logarithmic complex function. The function is provided in equation 3. 
                ( )      
                 ( ) 
 
 
 This corrective function depends on the natural frequency ω, the parasitic capacitance 
CPAR and the measured impedance Zmeas(ω), and is plugged into the original equation for Td 
compensation, which is given in equation 4. 
               ( )       ( )   
       ( ) 
 The basic idea behind estimating the value of the parasitic capacitance (CPAR) is that the 
susceptance S, which is the complex component of admittance (Y), and where admittance is 
equal to the conductance summed with j*susceptance, of the parasitic capacitance increases in a 
linear manner with an increase in frequency. On the other hand, the susceptance of the 
impedance block that is being measured stays constant. So at high frequencies, it can be 
estimated that most of the susceptance of the measured admittance is provided by the parasitic 
capacitance (Buendia, 2010). 
 As a result of this approach, the Hook Effect can be completely removed from the 
reactance spectrum of the measured impedance. Although this method is extremely effective, it 
is fairly difficult to estimate the parasitic capacitance as ideally measurements need to be taken at 
very high frequencies (Buendia, 2010). 
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Novel Dry ECG Electrodes 
 Gel electrodes used currently for recording ECGs pose several problems including long-
time stability, reduced contact impedance, and reduced motion artifacts.  Doctors want the ability 
to record over a much longer period of time.  However, due to shelf life and electrode 
dehydration, gel electrodes can only be used to record signals for a few days at maximum.  
Dehydration of the electrode causes noise in the recorded signal.  Motion artifacts, another issue 
encountered when using gel electrodes, are a result of patient movement, electrode placement, 
breathing, or stretching of the skin under the electrode.  These signals can be mistaken as extra 
systolic measurement from the heart, resulting in an inaccurate ECG (Gruetzmann, 2007). 
 Dry electrodes also present a few problems.  They are composed of metal plates, and shift 
when the patient moves.  The resulting recording is incorrect because of this shifting.  The skin is 
sometimes punctured in order to use the dry electrodes.  This method does not allow for long 
term recording either, because scar tissue grows around the electrode and isolates it.  The issue of 
impedance is somewhat addressed with dry electrodes, because if the electrode has a tight 
connection with the skin, the skin will moisturize and the impedance will drop (Gruetzmann, 
2007). 
 In order to address the problems faced when using dry electrodes and gel electrodes, a 
novel electrode was designed.  This new technology was a soft, dry foam electrode.  The 
material allows it to adapt to the contact area, including any curves of the skin and hair.  It also 
has an increased contact area with the skin.  Unlike the dry electrodes, the foam electrode 
remains in contact with the skin during movement.  The foam makes it so that a charge is not 
induced when the electrode rubs on the skin.  Due to the flexibility of the material, the electrode 
works on hairy skin, whereas previous rigid dry electrodes do not (Gruetzmann, 2007). 
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 After testing these electrodes, the author found that the foam electrode impedance on 
hairy skin is about the same as the impedance of the dry electrodes on hairless skin.  This 
demonstrates that it would not be necessary to shave the contact area of skin when using the 
foam electrodes.  The foam electrodes also reduce motion artifacts because they have the most 
intimate contact with the skin, and adapt to any movements made by the patient.  No gel is 
necessary with the foam electrodes, so the author believes that they will have a longer stability, 
and be able to be used for recording for longer periods of time than gel electrodes.  The problems 
of the foam electrodes are that they need an improved adhesion layer, and the foam needs to be 
stabilized.  The author proposed that the stabilization can be done by using a cup-like packaging, 
similar to that of gel electrodes (Gruetzmann, 2007). 
CNT/PDMS Electrodes 
 Carbon nanotubes (CNT) are becoming ubiquitous in the medical market for several 
applications. In the domain of electrocardiography CNTs can be used as a replacement medium 
for silver chloride gels. The dry contact offered by CNT electrodes reduces the impedance, 
increases bio-compatibility and allows many physical forms to be fabricated (Jung, 2012). These 
electrodes also allow long term potentiation for bio-electric signals, whereas previous gel based 
electrodes increase in impedance as the gel dehydrates (Jung, 2012). 
 Initial fabrication techniques for CNT based electrodes use a polydimethylsiloxane 
(PDMS) dispersion material. Chemical vapor deposition of the CNT and PDMS allowed purity 
concentrations greater than 90% (Jung, 2012). To reduce aggregates, which impede signal 
potentiation, a hydrodynamic dispersion was applied through mechanical force to the 
CNT/PDMS mixture. The machine applied the mechanical dispersion force by dispersing small 
amounts of solid material onto any liquid materials through a chrome plated hardened steel roller 
 OPTIMIZING NOVEL ECG ELECTRODES  19 
 
 
(EXAKT 50, EXAKT Technologies Inc., Oklahoma City, OK). The CNT dispersion was then 
placed into a shear flow system between five and fifteen hours. The CNT then homogeneously 
dispersed in PDMS (Jung, 2012). 
 Using a master mold which combined a petri dish, an acrylic layer and a snap, the PDMS 
precursor of liquid pre-polymer and a crosslinking agent was poured into the master mold. This 
mold was then cured at 80º C for two hours (Jung, 2012). The PDMS master mold was separated 
from the petri dish and the acrylic layer was removed from the mold. The CNT/PDMS composite 
was then poured into the PDMS master mold and again thermally cured at 80º C for two hours. 
PDMS was separated from the CNT/PDMS electrode using methanol (Jung, 2012). After 
separation the electrodes were connected to an impedance analyzer which modulated with a 50 
mV excitation in the range between 10 and 100 kHz. The CNT/PDMS electrodes were bent to 
measure strain impedance and mechanical stress-strain curves were derived from the results 
generated by a universal testing machine (Jung, 2012). A BIOPAC ECG amplifier generated the 
ECG signals from the electrodes placed at the forearms and left leg of several persons. These 
electrodes were measured under dry conditions and motion artifacts were measured while the 
ECG subject was walking at a 3 to 5 km/h rate. Cytotoxity and skin compatibility tests were 
committed by growing cell cultures onto the electrodes and measuring cell growth rates; the skin 
compatibility tests were performed by measuring ECG signals from the forearm for seven days 
with clinical tape. 
 Nine electrodes each having increased thickness and diameter were used for signal 
testing, and four groups of nine with different percent weights were allocated. Impedance 
decreases with increasing signal frequency and diameter. For each case of percent weight [1%, 
1.5%, 2%, 4.5%] CNT/PDMS ratio and diameter [2cm, 3cm & 4cm] electrodes the dry contact 
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impedance was over 10
6
 Ohms at frequencies less than 102 Hz, and around 10
3
 Ohms at 
frequencies greater than 105 Hz with a linear curve between (Jung, 2012). These impedances do 
not pass the AAMI EC12-2000-4.2.2.4 impedance requirement. Strain deviated the electrical 
conductivity by about a single order of magnitude while the stress-strain curves had larger 
Young’s Modulus for greater percent weight ratios. For signal quality the signal amplitude vastly 
increased with higher percent CNT/PDMS ratios. Sweat conditions did not reduce signal quality 
and slight noise was observed for motion testing at normal walking rates (Jung, 2012). Skin 
compatibility tests under the seven day wearing condition showed no itching or erythema. The 
cellular biocompatibility tests showed normal cellular growth within cultures that were directly 
exposed to the CNT/PDMS medium. Viability of cells on all electrodes was over 95%, giving 
highly significant reason for the researchers to state that “CNT/PDMS composite did not affect 
cell growth” (Jung, 2012). 
 The CNT/PDMS electrodes show quality signals, biocompatibility, ease of fabrication 
and long term potentiation of bio signals which gel ECG mediums do not exhibit. The 
CNT/PDMS electrodes are easy to clean with an alcohol solution, with no expected signal loss 
occurring. This result allows reusability of the CNT/PDMS electrodes where current AgCl 
electrodes are usually short term and one time use materials. 
Pressure Sensitive Adhesive by FLEXcon 
FLEXcon has a wide range of PSA products with several applications. One product they 
have is the THINflex CLEAR Pressure Sensitive Adhesive which offers resistance in shrinking 
and can be used in ice chest, pasteurization, moisture and humidity products. It has a good 
acrylic adhesive bond on glass and high surface energy products which will be resistant to lifting, 
tunneling and flagging over time. Some of its properties are listed in Appendix A, Fig. 50. 
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Properties include the materials ability to have strong adhesive bonds on various metals, 
polymers and ceramics, making it extremely universal. The adhesive is available in various 
forms such as a tape or roll (FLEXcon).  
ECG Correlated with Different Skin Types 
 Since skin is a poor conductor of electricity due to its density and other factors, it has the 
potential to distort an ECG signal being picked up from within the body. The outer layer of the 
skin, known as the epidermis, is mainly the problem layer because it has a frequency and 
amplitude higher than the actual ECG signal. It is also difficult to filter electronically. This type 
of distortion coupled with 60Hz interference from power lines can result in complicated signals 
that are not easy understand even after filtering. Research from the National Teaching Institute & 
Critical Care Exposition(AACN NTI) have shown that the skin-electrode interface in many 
healthcare establishments are overlooked and a simple change, such as in prepping the patients 
skin properly greatly increase the quality of the ECG signal (Philips, 2008).  
 The type of skin a person has plays a key role in improving the overall efficiency of 
acquiring a quality ECG signal. Patients with dry or dead epidermal layers of skin should have it 
removed before having electrodes placed on to them, because this type of skin increases the 
impedance. Natural oils and dirt should also be removed as they too can create resistance to 
signal quality and prevent electrical flow. Studies by 3M have shown that after using their prep 
pads, the new measured skin resistance was 20 kΩ, compared to the average impedance of skin 
which is a about 345kΩ (3M, 2009). 
 Many common procedures are followed in preparing the skin of the patient before the 
placement of electrodes. The area of the patient’s skin where the electrode will be placed needs 
to be shaved because hair prevents good electrode-skin contact. Soap and water, a non-alcoholic 
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wipe or a small piece of abrasive ECG skin prep paper can be used in order to improve the 
conductivity of the skin. Alcohol dries the skin out so it is not advised to be used for cleaning, as 
it diminishes electrical flow. The site of placement should also be dried in order to increase the 
capillary blood flow into tissue. Figure 8. depicts the layers of the epidermis on which the 
electrode would rest. 
 
Fig. 8: Cross section of Epidermis 
Biomedical Signal Processing 
 Biomedical signals are classified as the outputs of a sensing device.  In order to read and 
analyze the signals as accurately as possible, it is necessary to process the recordings.  Signal 
processing plays a key role in understanding recorded signals.  It can either be used to extract 
parts of the signal, or to represent the signal in an alternate way (Luo, 2010.).  Signal processing 
is important for recording ECGs because it allows doctors to eliminate noise to better classify 
and detect the recordings.  It also allows for the most accurate interpretations of the recordings, 
and allows doctors to focus on specific waves of the heartbeat (Aston, 1990).  
 Filters are a key tool for signal processing.  There are several different types of filters 
used to attenuate unwanted frequencies, such as noise, from the input signal.  A common type of 
filter used for signal processing is the Butterworth filter, which provides a flat passband.  This 
classification of filters includes low pass, high pass, band pass, and band stop filters, all of which 
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can be seen below in Error! Reference source not found.9.  These all pass signals that have 
requencies in the passband, and reject signals in the stopband.  Low pass filters pass signals that 
are below a certain cutoff frequency.  High pass filters pass signals with frequencies above the 
cutoff.  Band pass filters only pass frequencies within a certain range, and band stop filters pass 
all frequencies except those in a certain band. 
 
Fig. 9: Different types of Butterworth filters (Filter image) 
Filtering a signal sometimes causes problems, such as magnitude distortion.  This occurs 
when the frequency of the unwanted signal overlaps that of the desired signal.  When the noise is 
attenuated, the magnitude of the signal is distorted as well.  In order to record an accurate ECG, a 
technique called oversampling is used.  This means that the ECG sampling rate is orders of 
magnitudes larger than the desired sampling rate, to allow for filtering of the recorded signal.  
The signal is processed using a low pass filter to avoid noise, and then down-sampled to the 
desired sampling rate so that it is not aliased (Luo, 2010.). Aliasing occurs when the analog 
signal picked up from the electrodes is sampled at a frequency lower than twice the bandwidth of 
the signal. 
Line-frequency filters (LFF) are used when filtering ECG recordings.  They get rid of 50-
60Hz power line interference noise, which is encountered in a clinical setting.  The LLF is a 
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band stop filter that is activated constantly during the recording.  This means that it passes most 
frequencies, and only attenuates those within the specified range.  The specified range of signals 
to attenuate is narrow, and only includes the frequency of the power line noise. 
A novel idea for filtering is to integrate the filter into the electrode set up (Gruetzmann, 
2007).  This would eliminate motion artifacts caused by movements and breathing, because it 
would remove the unwanted signals starting at their origin.  The setup for this filtering technique 
is putting a high pass filter at the origin of the signal. 
Electrophoresis 
 Electrophoresis is defined as “a technique used for the separation of biological molecules 
based on their movement due to the influence of a direct electric current” (Lerner, 2008). The 
technique was first used by Arne Tiselius, a Swedish chemist, which won him a Nobel Prize in 
1948 (Berger, 2001). In electrophoresis charged biomolecules, such as carbon structures, are 
placed within a medium. Electrodes are placed on two sides of the medium and a current is 
applied. When the current is applied to the medium, the positively charged particles move 
towards the anode, and the negatively charged particles move towards the cathode (Lerner, 
2008). In gel electrophoresis, the medium used has adjustable density and pore size of the gel 
matrix which allows filtering based on molecular size of the particles (Lerner, 2008). 
 General media to apply electrophoretic techniques on include: (i) paper, (ii) thin-layer 
plates and (iii) gels (Berger, 2001).  One important aspect of particle behaviors in electrophoretic 
fields is their isoelectric points. When migrating under the field, displacement is greatest when 
the difference between the isoelectric point and the pH are greatest. For an equivalent pH and 
isoelectric point, the particle has zero force and displacement ends within the medium (Berger, 
2001).  
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 When a strong electric field in the hundreds of volts per centimeter range is applied, a 
non-linear electrophoretic effect is detected (Barany, 2009). The first non-linear effect is 
encapsulated between the outer field and the field-induced ionic charges in the electric double 
layer. The second non-linear effect is due to the concentration polarization (Barany, 2009). The 
classical theory of electrophoresis can be described by equation 5: 
                
   
   
 
Veph is the velocity of electrophoresis, ε is the permittivity of the medium, Ϛ is the electrokinetic 
potential, E is the external field gradient, and n is the viscosity of the medium. When the velocity 
of the electrophoretic movement of particles is proportional to the strength of the applied field 
then the electrophoresis is linear. However, when the strong electric field is applied the 
dependence of Veph becomes nonlinear with respect to E. The first non-linear theory of 
electrophoresis can then be described by equation 6: 
                    (  )
  
µ describes the cubic electrophoretic effect for spherical particles (Barany, 2009). The net force a 
particle experiences can then be described in terms of the surface conductivity and the 
conductivity of the medium, with particle radius a, as described in equation 7: 
             
  
    
 
For the second non-linearity, described as superfast electrophoresis, the conditions which 
promote this behavior are the existence of current within the particle, unipolar conductivity of 
the particle’s material, higher conductivity of particles with respect to the medium conductivity, 
and large electric field gradients (Barany, 2009). 
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Properties of Carbon 
 To describe the electronegativity of Carbon in the normal state the following parabolic 
Hamiltonian is applied to the Schrodinger differential: 
 
The energy states of Carbon can then be solved explicitly as shown in equation 8 (Putz, 2011): 
               
      
  (   )
     
 
E0 is the ground state energy level, λ is the de Broglie wavelength and p0 is the density of the 
atomic structure. To approximate the electronegativity of Carbon the frontier orbital must be 
defined. This orbital is the barrier between occupied and unoccupied orbitals (Ahn, 2007). Since 
the majority of electromagnetic interactions happen at this barrier the frontier orbital 
electronegativity can be approximated as shown in equation 9, (Putz, 2011): 
               
  
  
                              
Several features of carbon are listed in Table 1. 
Table 1: Properties of Carbon-12 
Property Value Reference 
Ground State Configuration 3P0 (Johansson, 1966) 
Ionization Energy 11.2603 eV (Johansson, 1966) 
Atomic Mass 12.0000 u (Krane, 1988) 
Abundance 98.89% (Krane, 1988) 
Atomic Radius 76.7 pm (Alcock, 2007) 
 
Carbon black is defined as “any of a group of intensely black, finely divided forms of 
amorphous carbon, usually obtained as soot from partial combustion of hydrocarbons…” 
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(Britannica, 2012). Carbon black atoms are spherical in shape and changes into graphite at 
3000*C. Doping of ceramic materials with carbon black causes several changes in the 
piezoelectric properties of the material. Doping cement with 0.3% carbon black increases the 
piezoelectric strain by a factor of 1.5 relative to 100% and 0% doping (Shifeng Huang, 2009). 
Figure 10. illustrates the relative impedance by percent weight of carbon black and applied 
frequencies in the material: 
 
Fig. 10: Impedance spectra of the composites with different carbon black content (Shifeng Huang, 2009) 
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4. Materials & Methods 
Materials for Electrode Design 
 The materials used for the fabrication of the electrodes consist of the following: 
 Pressure sensitive adhesive: V-95 
 Dopent: carbon dispersion 
 Liner 1: 200 Poly SC-6 
 Liner 2: 100 Poly H-9 
 Film: PM200W TC-200 EXV-215 
 Magnetic mixer 
 Beaker 
 Pipette 
 12mil spreading tool 
 
Methods for Electrode Design 
 In order to create a 30g mixture to make electrodes, the dopant and the PSA are added to 
a beaker using two pipettes taped together.  The amount of carbon added is the percent to be 
tested out of 30g.  The rest of the mixture is composed of PSA.  Once the 30g mixture is created, 
a magnetic mixer is used for about 40 minutes to stir the PSA and dopant.  Next, this mixture is 
spread onto a liner using the 12mil spreading tool.  The liner is then placed in a 160° F oven for 
10 minutes.  After this drying process, the liner is cut into 1” pieces in order to make the 
electrodes.  The film is cut into 1.5” pieces, and the liner is removed from the adhesive.  The 
adhesive is placed onto the film, leaving a small amount of adhesive exposed, in order to prevent 
the electrode from shorting.   
 Activation was obtained by applying electrophoresis across the X-Y plane of each 
electrode. Defibrillation charge testing, based on the AAMI EC12-2000-5.2.2.4 overload circuit 
diagram, applied the electrophoresis to the electrode films. Carbon columns formed to indicate 
activation was successful. A voltage meter applied across the activation capacitor checked to see 
if the electrode was shorted during application of two electrode adhesives. If the voltage slowly 
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decayed from 200 V the electrode was shorted, otherwise upon activation this voltage was 
reduced to micro-volts. The electrodes were then removed and two impedance testing clips were 
attached to the activation points of the material. A 10 Hz signal from the impedance testing 
device was generated and the impedance was measured.  
Materials for Activation Device Design 
Table 2: List of parts needed to build the activation circuit. 
Part Quantity 
PC BOARD CEM1 EPOXYGLASS 1 
SWITCH DIP PIANO SEALED 10POS 3 
DIODE GP 1A 800V DO41 8 
SW TOGGLE SPST ON-OFF SOLDER LUG 2 
BOX FIBER 13.8X11.9X6.47" GREY 1 
BOX NEMA ECONOMY 5.9X5.9X3.54 1 
Resistors  
RES 1.00K OHM 1W 5% AXIAL 3 
RES 2K OHM 1W 5% METAL OXIDE 3 
RES 4.0K OHM 5% WW AXIAL 3 
RES 6.0K OHM 5% WW AXIAL 3 
RES 8.0K OHM 5% WW AXIAL 3 
RES 10.0K OHM 1W 5% AXIAL 3 
RES 5W 10K OHM 5% WIREWOUND 3 
RES 12K OHM 1W 5% METAL OXIDE 3 
RES 14.0K OHM 1/2W 1% AXIAL 3 
RES 18K OHM 1W 5% METAL OXIDE 3 
RES 20K OHM 1W 5% METAL OXIDE 3 
RES 22K OHM 1W 5% METAL OXIDE 3 
RES 26K OHM 1/2W 0.1% AXIAL 3 
RES 30K OHM 1W 5% METAL OXIDE 21 
RES 34.0K OHM METAL FILM .60W 1% 3 
RES 38K OHM 1/2W 0.1% AXIAL 3 
RES 40K OHM 1/2W 0.1% AXIAL 3 
RES 50K OHM 1/2W 1% AXIAL 3 
RES 60K OHM 1/2W 0.1% AXIAL 3 
RES 70K OHM 1/2W 1% AXIAL 3 
RES 80K OHM 1/2W 1% AXIAL 3 
RES 90K OHM 1/2W 0.1% AXIAL 3 
RES 100K OHM 1W 5% METAL FILM 15 
RES 110K OHM 1W 5% METAL OXIDE 3 
RES 130K OHM 1W 5% METAL OXIDE 3 
RES 150K OHM 1W 5% METAL FILM 3 
RES 210K OHM 1/2W 0.1% AXIAL 3 
Capacitors  
CAP 0.1UF 400W AXIAL 3 
CAP 1.0UF 400W AXIAL 3 
CAP 10.0UF 400W AXIAL 3 
CAP 100.0UF 400W AXIAL 3 
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Methods for Activation Device Design 
 An activation device with variable parameters was designed and built.  The parameters 
required by FLEXcon are listed in Table 3.  Each parameter value was permutated with the other 
parameters in order to determine the optimum activation of electrodes, using the electrodes with 
10% carbon doping.  
Table 3: Variable parameters for electrode activation. 
Parameter: Values Units 
Voltage 5, 20, 45, 75, 120, 200 V 
Current 1, 2, 5, 10, 20, 50, 100 mA 
Frequency DC, 60, 1000 Hz 
Time 1, 10, 100, 1000 ms 
 
 The circuit layout was determined based on the AAMI standard defibrillation overload 
circuit. In order to vary parameters, dip switches were used to change values of resistors and 
capacitors.  Once the values of these parts were determined, the circuit was simulated using 
Multisim. The power supply used provides an AC voltage from 0-240 Volts, but the circuit based 
on the AAMI standards is typically used with a DC voltage.  In order to address this, a diode 
rectifier was designed at the input to the circuit to convert the voltage from AC to DC. Figure 11. 
depicts the block diagram of the activation circuit. 
 
Fig. 11. Activation Circuit Block Diagram 
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 For switches S1 and S2 there are two possible events that occur within the circuit. When 
S1 is on, and S2 is off, the voltage of the capacitor at steady state can be described as follows. 
               
  
   
      
Where VC is the capacitor voltage and VS is the power supply voltage. When S1 is off, and S2 is 
on, the electrode voltage and current can be approximated, with the electrode impedance ignored, 
and is shown in equations 11, and 12. 
                     
              
  
 
 
Where VE is the electrode voltage and VR is the voltage across the variable resistors and R is the 
resistance value.  
 To physically build the circuit, wires that support high power wattage were obtained from 
the Electrical and Computer Engineering (ECE) Shop, and all other parts listed in the materials 
section were ordered through the shop.  The parts were soldered onto the board based on the 
schematic.  The final board is shown below in Fig. 12, and the housing for the activation device 
can be seen in Fig. 13.  Once this was complete, the different sections of the board were tested 
using a digital multimeter to make sure everything was functioning properly.  After determining 
that the board was working correctly, the team assembled 840 electrodes, following the 
procedure laid out in the previous section, “Materials for Electrode Design.” 
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Fig. 12. Activation device with variable parameters. 
 
 
Fig. 13. Housing for the activation device. 
  
At first, an LCR meter from the Biomedical Engineering Lab in Goddard Hall was used 
for testing.  This meter was old and gave extremely variable impedance values; therefore it was 
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determined to be unreliable.  In order to address this issue, the Hiroki IM 3570 was rented in 
order to measure the impedances of the electrodes.  All pre-activation impedances of the 
electrodes were measured using this device at a frequency of 10 Hz and voltage of 1 V.  Once 
impedance measurements were taken, a sample size of N=5 electrodes were activated for each 
combination of the parameters listed in Table 3. The post-activation impedance measurements 
were taken for each electrode using the LCR meter. 
During this portion of the project, the group encountered several setbacks that were 
addressed.  Ordering parts through the ECE shop took an unnecessary amount of time because 
parts were out of stock, so a new part list needed to be created from a different supplier.  Also, 
finding an LCR meter that had the necessary functionality to measure impedances up to MΩs at 
a frequency of 10Hz was a problem.  Renting an LCR meter allow the large impedances to be 
recorded.  Finally, the variable power transformer used to activate the electrodes shorted a diode 
in the rectifier more than once and also melted a wire, which was determined by trouble shooting 
the activation device board. 
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5. Results 
Stage 1 
One of the primary deliverables of this qualifying project was to design an experiment 
which determines the ideal concentration of carbon dispersions in the novel ECG electrode 
which minimizes post activation impedance. Ideally, a minimal amount of carbon would be used. 
To narrow down on this, the group designed an initial experiment which tested electrodes created 
with varying concentrations of carbon [ranging from 2% to 12% carbon loading levels by 
increments of 2] and measured pre-activation and post-activation impedance. The results from 
the initial experiment are provided in Table 4. 
Table 4 Impedance test results for different carbon levels (STAGE 1) 
Carbon Load 
Mean Pre-activation Impedance & 
Standard Deviation (MΩ) 
Mean Post-activation Impedance 
& Standard Deviation (Ω) 
2% 10.8 ± 7.3 2,400,000 ± 3,240,000 
4% 7.5 ± 10.4 4960 ± 5400 
6% 5.6 ± 5.0 2900 ± 3000 
8% 6.9 ± 3.8 273 ± 35.4 
10% 3.3 ± 5.0 222 ± 24.6 
12% 1.99 ± 0.77 307 ± 35.2 
  
 For each carbon load level, 5 sample electrodes were used in this initial experiment. From 
Table 4 it can be observed that the most consistent results were obtained for carbon loads at 8%, 
10% and 12%. According to AAMI standards, the mean post activation impedance is required to 
be under 2KΩ. Based on that criterion, the group proceeded to the next stage of the experiment 
by gathering more data on impedance levels for 8%, 10% and 12% carbon levels.  
 For this part of the project, the group gathered 30 samples of each carbon load levels and 
performed a similar experiment on the pre-activation and post-activation impedance levels of the 
electrodes. There were a few outliers in the data that was collected. It is usually challenging to 
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define a data point as an outlier as no official statistical definition exists for it. For the purposes 
of this experiment, the group evaluated the first quartile Q1 [25
th
 percentile], the third quartile 
Q3 [75
th
 percentile] and the interquartile range IQR [Q3-Q1]. A factor of 1.5 was then multiplied 
to the IQR and subsequently added to Q3 and subtracted from Q1. Any data point that fell 
outside of this range was then considered an outlier. A MATLAB script was written to evaluate 
each data point and discern whether or not it was a valid data point that can be used for analysis. 
This script has been included in Appendix B. The data for central tendency in these samples is 
provided in Table 5. 
 
Table 5 Impedance Test Results, STAGE 1 
Carbon Load 
Mean Pre-activation Impedance  
& Standard Deviation (MΩ) 
Mean Post-activation Impedance 
& Standard Deviation (Ω) 
8% Carbon 10.5 ± 6.01 1170 ± 1170 
10% Carbon 2.09 ± 2.79 256 ± 51.4 
12% Carbon 3.96 ± 2.39 286 ± 56.5 
 
 After the removal of outliers, the remaining data was used to plot the Gaussian 
distribution for the samples. The MATLAB script for this has been included in Appendix B. 
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Fig. 14. Gaussian distribution plot for 8% carbon load 
 
 
Fig. 15. Gaussian distribution plot for 10% Carbon load 
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Fig. 16. Gaussian distribution for 12% carbon 
 
 In order to verify that the data gathered for pre-activation and post-activation impedances 
are not from a random sample, two-tailed t-tests were performed in MATLAB. The t-tests were 
done with a set null hypothesis that at a significance level of 95%, the data in the given vector 
are a random sample from a normal distribution with a mean of zero and unknown variance. The 
following results were obtained and have been provided in Table 6. It should be noted that the p-
value returned from the t test provides the probability of obtaining a result more extreme than the 
test statistic. At a significance level of 95%, the p value tells us what the chances of obtaining a 
result that is more extreme than this confidence interval. 
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Table 6 One sample t-test results 
Sample Rejection of Null hypothesis p-value 
8%, pre activation Yes 1.5*10
-9
 
8%, post activation Yes 1.1*10
-5
 
10%, pre activation Yes 7.8*10
-4 
10%, post activation Yes 8.5*10
-21 
12%, pre activation Yes 7.5*10
-10 
12%, post activation Yes 5.3*10
-21 
 
 Following this, two sample t-tests were done to observe whether the data gathered from 
8%, 10% and 12% were inherently collected from separate populations or not. The null 
hypothesis was that the two datasets had equal population means and equal but unknown 
variances. The results are given in Table 7. 
Table 7 Two sample t-test results 
Samples Rejection of Null hypothesis p-value 
10% and 8%, pre activation Yes 2.0*10
-8
 
10% and 8%, post activation Yes 7.0*10
-5
 
12% and 10%, pre activation Yes 0.0086
 
12% and 10%, post activation Yes 0.0396
 
8% and 12%, pre activation Yes 9.5*10
-7 
8% and 12%, post activation Yes 1.1*10
-4 
 
 As expected, the p-value for the 12% and 10% distribution was higher than the rest. This 
is because the sample means for both of these datasets are comparable to each other. However, 
the post activation p-value was still lower than 0.05, which means that they can be recognized as 
two independent populations. It is preferred to limit the amount of carbon black in the PSA-
carbon mixture. Therefore, the group has decided to use 10% carbon in the future electrodes to 
be designed, due to the consistency in post activation impedance in 10% carbon. 
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 Pre-activation and post-activation impedances were recorded for 840 electrodes. The 
parameters were varied and the complete mean and standard deviation results are included in 
Appendix E. The following code listing was used to derive the mean and standard deviation from 
the list of measurements. 
clc; clear all; close all; 
  
data=xlsread('Impedance Measurements 12-13.xlsx'); 
n=1; 
for i=1:5:840 
    for j=1:1:5 
        if i==1 
            read(j)=data(j,2)*10^(data(j,3)); 
        else 
            read(j)=data(i+j,2)*10^(data(i+j,3)); 
        end 
    end 
    mean_data(n)=mean(read); 
    std_data(n)=std(read); 
    n=n+1; 
end 
  
    mean_data=mean_data'; 
    std_data=std_data'; 
 
     
 Figures 17- 20. show the variation of power across the electrode for a 0.1 uF, 1.0 uF, 10.0 
uF, and 100.0 uF capacitor respectively, and the resulting averaged impedances for each 
activation power. 
 
Fig. 17. 0.1 uF Post-Activation Mean Impedances 
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Fig. 18. 1.0 uF Post-Activation Mean Impedances 
 
Fig. 19. 10.0 uF Post-Activation Mean Impedances 
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Fig. 20. 100.0 uF Post-Activation Mean Impedances 
 The mean post-impedance trend implies that for higher activation powers the impedance 
tends to drop exponentially, with a greater rate of decrease for larger capacitor values. Using 
larger capacitors causes the activation time to increase and can be correlated with the drop in 
impedance. 
 Table 8 details the specific mean and standard deviation values for low post-activation 
impedances. These values correspond to the optimum activation parameters for the current data 
set. 
Table 8 Optimum Parameters for Activation 
Parameters Pre-Activation [Ω] Post-Activation [Ω] 
Voltage Capacitance Current MEAN STD MEAN STD 
200V .1µF 20mA 18835105 3706363 3678.83 1875.343 
200V .1µF 100mA 17177040 8404301 6040.96 6671.187 
200V 1µF 10mA 20869620 2340181 2412.112 1342.27 
120V 1µF 10mA 7827510 9834031 1247.771 262.3298 
200V 1µF 100mA 20716840 2772424 443.5232 189.509 
120V 1µF 100mA 20636080 3326407 829.6632 296.6535 
200V 10µF 10mA 21570320 3224722 1673.75 494.7733 
200V 10µF 20mA 15640541 8898123 1195.448 2161.881 
120V 10µF 20mA 21097100 1966878 1048.699 1506.763 
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 From Table 8 the optimum activation parameters are 1 µF, 200 V and 100 mA of current. 
However, using the 100 mA current results in carbon columns that expand until they burst, 
resulting in smoke. Therefore the 50 mA current may be the optimum current for activation. 
 Extra electrode testing was conducted over the Winter break. However, the data derived 
was from a carbon and PSA mix that settled over a month and generated very large impedances. 
These impedance values are found in Table 9. 
Table 9 Settled Carbon and PSA Mixed Impedance Values 
Voltage [V] Capacitance [uF] Current [mA] Post Impedance [Z] 
120 1 10 3421039.54500000 
200 1 100 2043.68715000000 
120 1 100 20805957.5070000 
200 10 10 5459910.94300000 
200 10 20 34753.8865000000 
120 10 20 14812342.5075000 
200 10 50 3615684.59400000 
200 100 10 2311178.29550000 
200 100 20 2830.16400000000 
200 100 50 1452770.11895000 
 
 Since the 200 V, 100 mA, 1 uF activation parameter generated the lowest impedance, this 
activation parameter was retested with a properly mixed solution. Figure 21. depicts the 
Gaussian distribution of post-activation impedances. 
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Fig. 21: Properly mixed PSA+Carbon Post Impedance Gaussian Curve 
 The mean of 43 activation electrode impedances is 875 Ω, and the standard deviation is 
657 Ω. These values are under the AAMI requirements of 2 kΩ mean and no single activation 
impedance exceeding 3 kΩ. Due to the AAMI requirements being met for the 10% doped carbon 
and PSA mix, activated at 200 V, 100 mA, with a 1 uF capacitor, these electrodes meet all 
requirements for the next stage of the project. 
Stage 2 
 Four electrode types are tested for their impedance vs. frequency characteristics. Three 
FLEXcon electrodes of sizes [Width x Height]: 3.5 cm x 2.5 cm, 4 cm x 3 cm, and 5 cm x 4 cm. 
The fourth electrode is the standard tab Ag-AgCl electrode for comparison testing, and is 
approximately the same size as the smallest FLEXcon electrode. Two electrodes were mounted 
on the right forearm, one by the palm side of the wrist, and the second was 5 cm away towards 
the elbow. These electrodes were connected to the Hioki IM3570 impedance analyzer. Figure 22. 
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depicts the impedance vs. frequency sweep of the Ag-AgCl electrodes. Figures 23- 25. depict the 
impedance vs. frequency sweeps for small, medium, and the largest FLEXcon electrodes 
respectively. 
 
Fig. 22. Impedance vs. Frequency sweep for Ag-AgCl electrodes. 
 
Fig. 23. Impedance vs. Frequency sweep for small FLEXcon electrodes. 
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Fig. 24. Impedance vs. Frequency sweep for medium FLEXcon electrodes. 
 
Fig. 25. Impedance vs. Frequency sweep for large FLEXcon electrodes. 
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movement was conducted for the second waveform recorded. Figure 26. depicts the Ag-AgCl 
electrode ECG waveform for a participant at rest. 
 
Fig. 26. Ag-AgCl resting ECG waveform for 2 second period. 
The waveform shows a consistent signal-to-noise ratio (SNR), with baseline amplitude 
oscillations of noise present. The PQST waves are generally indiscernible due to the noise, yet 
the R wave is readily apparent. Figure 27. Depicts the Fast Fourier Transform of the resting Ag-
AgCl waveform. 
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Fig. 27. FFT of resting Ag-AgCl ECG waveform. 
Figures 28., and 29. Depict the ECG waveform and the FFT of the Ag-AgCl electrodes when 
movement occurs every ten seconds for the span of one minute. The movement shown on Fig. 
28. Begins at the 20 s mark. 
 
Fig. 28. Movement ECG waveform for Ag-AgCl electrodes. 
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Fig. 29. FFT of movement Ag-AgCl ECG waveform. 
Figures 30., and 31. depict the resting ECG waveform and FFT of the small FLEXcon 
electrodes. Figures 32., and 33. depict the movement ECG waveform and FFT of the small 
FLEXcon electrodes. 
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Fig. 30. Resting ECG waveform for small FLEXcon electrodes. 
 
Fig. 31. FFT of resting small FLEXcon ECG waveform. 
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Fig. 32. Movement ECG waveform for small FLEXcon electrodes. 
 
Fig. 33. FFT of movement small FLEXcon ECG waveform. 
Figures 34., and 35. depict the resting ECG waveform and FFT of the medium FLEXcon 
electrodes. Figures 36., and 37. depict the movement ECG waveform and FFT of the medium 
FLEXcon electrodes. 
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Fig. 34. Resting ECG waveform for medium FLEXcon electrodes. 
 
Fig. 35. FFT of resting medium FLEXcon ECG waveform. 
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Fig. 36. Movement ECG waveform for medium FLEXcon electrodes. 
 
Fig. 37. FFT of movement medium FLEXcon ECG waveform. 
Figures 38., and 39. depict the resting ECG waveform and FFT of the large FLEXcon electrodes. 
Figures 40., and 41. depict the movement ECG waveform and FFT of the large FLEXcon 
electrodes. 
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Fig. 38. Resting ECG waveform forlarge FLEXcon electrodes. 
 
Fig. 39. FFT of resting large FLEXcon ECG waveform. 
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Fig. 40. Movement ECG waveform for large FLEXcon electrodes. 
 
Fig. 41. FFT of movement large FLEXcon ECG waveform. 
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Signal Processing and Peak Detection Algorithm 
 This section covers the signal processing steps that were taken to clean up the raw ECG 
data collected from the ten subjects using a Rozinn© holter monitor as part of this study. It also 
covers the method used to detect the QRS peak locations in the data. Peak detection is crucial for 
comparing the data gathered from silver/silver chloride electrodes against the novel ECG 
electrodes manufactured by FLEXcon. The team used the scripting language MATLAB to 
process the data and implement the peak detection algorithm. 
Import Raw Data, Sampling Frequency, time vector 
 The raw ECG data was collected using a Rozinn© holter monitor. This brand of holter 
monitors is capable of gathering ECG data from multiple channels simultaneously. As a result, 
ECG data was saved from silver/silver chloride electrodes and from FLEXcon electrodes at the 
same time in .csv files. The code used to import the data from both these channels has been 
provided below. 
%% Read data 
ecg= csvread('32223.csv'); 
ecg1= ecg(1:32400,3)./1000;   %FLEXcon electrode data, in Volts 
ecg2= ecg(1:32400,2)./1000;   %silver chloride data, in Volts 
% All flexcon variables end with 1, silver with 2 % 
 
 The MATLAB function csvread imports the data into a 3xN matrix, and individual 
channels are then extracted as shown above. All subsequent variables are named with a “1” at the 
end to indicate FLEXcon data and “2” to indicate silver/silver chloride data. Three minutes of 
resting ECG data was used for both channels. 
 Following this, the sampling frequency of 180 Hz was used to generate a time vector 
which was three minutes long. The variable duration stored the length of time in seconds of the 
ECG data. The time vector was transposed to a column vector to match the raw ECG data 
extracted previously. 
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%% Sampling frequency, time vector 
Fs=180; %sampling frequency of Rozinn holter monitor    
dt=1/Fs; %time increment 
duration=length(ecg1)*dt;   %length of data (180 seconds)   
t=0:dt:duration-dt; %time vector 
t=t';   %transpose time vector for detrending 
 
Detrending Solution, Correction for DC noise 
 One of the problems that are often encountered when analyzing ECG data is the presence 
of low frequency oscillations that occur as a consequence of breathing. Detrending the data 
involves the generation of a polynomial for each second of the data collected and subtracting it 
out of the raw signal. This is extremely important as the peak detection algorithm assumes that 
the amplitudes of the QRS complexes detected are on a comparable order of magnitude, and the 
presence of low frequency breathing artifacts may skew the analysis. Following this, the mean of 
the entire ECG signal was calculated for both channels and subtracted from the data to correct 
for DC offset. Figure 42. shows the resulting ECG waveform after these steps. 
%% Detrending solution 
N=180;  %length for detrending solution, 1 second long 
for i=1:N:length(ecg1)-N-1 
    p1=polyfit(t(i:(i+N-1)),ecg1(i:(i+N-1)),1); %generate coefficients for polynomial for 
FLEXcon 
    yfit1=polyval(p1,t(i:(i+N-1))); %create data set to be subtracted from raw ECG data, 
FLEXcon 
    p2=polyfit(t(i:(i+N-1)),ecg2(i:(i+N-1)),1);%generate coefficients for polynomial for 
silver chloride 
    yfit2=polyval(p2,t(i:(i+N-1)));%create data set to be subtracted from raw ECG data, 
silver chloride 
    for j=1:N 
        ecg1(i+j-1)=ecg1(i+j-1)-yfit1(j);   %detrend the raw data, FLEXcon 
        ecg2(i+j-1)=ecg2(i+j-1)-yfit2(j);   %detrend the raw data, silver chloride 
    end 
end 
%% Correction for DC noise level for threshold 
ecg1=ecg1-mean(ecg1);   %zeros the ECG essentially 
ecg2=ecg2-mean(ecg2);   %silver 
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Fig. 42. Raw ECG after detrending and DC correction. FLEXcon data is shown in blue, whereas silver chloride data is in red. 
Bandpass Filtering 
 The relevant data in an ECG signal rests between 5 and 11 Hz. Power line interference 
occurring at multiples of 60 Hz and low frequency baseline drift noise could be minimized by 
this step. To attenuate signal components that occur at frequencies outside this range, the data 
was first lowpass filtered with a cutoff at 11 Hz and subsequently highpass filtered with a cutoff 
at 5 Hz. The code to perform this is shown below. 
%% Lowpass filtering 
bl=[1 0 0 0 0 0 -2 0 0 0 0 0 1]; 
al=[1 -2 1]; 
ecg_lp1=filter(bl,al,ecg1); % Lowpass filter FLEXcon data 
ecg_lp2=filter(bl,al,ecg2); % LP filter silver data 
  
%% Highpass filtering 
bh=[-1 zeros(1,15) 32 zeros(1,15) 1]; 
ah=[1 1]; 
ecg_hp1=filter(bh,ah,ecg_lp1);  %HP filter FLEXcon 
ecg_hp2=filter(bh,ah,ecg_lp2);  %HP filter AgCl 
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 The second order lowpass filter implemented can be expressed by the following equation. 
This equation effectively retains all signal components that occur between 0 Hz and 11 Hz and 
attenuates higher frequencies by a factor of 36. 
 (  )    (    )   (     )   (  )    (     )   (      ) 
 After lowpass filtering was done on the ECG data from both channels, it was passed 
through a highpass filter with a cutoff at 5 Hz expressed by the following difference equation. 
The peak detection algorithm uses this data set to express the peak locations. 
 (  )     (      )   (    )   (  )   (      ) 
Derivative Filtering, Squaring 
 After the raw ECG signal is filtered to retain the significant components, it was passed 
through a derivative filter for peak detection. A five point derivative filter accentuates the slope 
of the QRS complex significantly, making it easier for the peak detection algorithm to detect 
QRS complexes. Following the derivative filtering, the signal was squared to provide nonlinear 
amplification to the peaks. The difference equation for the five point derivative filter is provided 
as follows, along with the MATLAB implementation of this step. 
 (  )  (
 
  
)    (     )    (     )    (    ) (     ) 
%% Derivative filtering, squaring 
bd=(1/8)*[2 1 0 -1 -2]; 
ad=[1]; 
ecg_der1=filter(bd,ad, ecg_hp1);    %derivative filter FLEXcon 
ecg_der2=filter(bd,ad, ecg_hp2);    %derivative filter AgCl 
  
ecg_sq1=(ecg_der1).^2; 
ecg_sq2=(ecg_der2).^2; 
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Moving Average Filtering 
This is a critical step in peak detection. The general idea is that by averaging signal 
amplitude for a certain predefined window length, the exact peak location can be picked out from 
the output of the squaring algorithm. For a sampling rate of 180 Hz, a window length of 30 is 
used to integrate the signal, as instructed in “A Real-Time QRS Detection Algorithm” by Pan 
and Tompkins. The difference equation for this step is provided below. ‘N’ stands for the 
window length, which has been selected to be 30 for this algorithm. Too large a moving window 
length can potentially result in peaks being missed, whereas too small a window length can give 
rise to multiple peaks in the integration waveform. 
 (  )  (
 
 
)   (   (   ) )   (   (   ) )     (  )  
%% Moving average filtering 
N=30;   %length of MA filter  
bm=(1/N)*[ones(1,N)]; 
am=[1]; 
ecg_m1=filter(bm,am,ecg_sq1);   %MA filter FLEXcon 
ecg_m2=filter(bm,am,ecg_sq2);   %MA filter AgCl 
 
Thresholding, peak indices search 
 After the signal has passed through a moving average filter, thresholds were set to be 
equal to the mean of the output of the moving average filters. Any data point that is detected to 
be higher than the threshold in amplitude is deemed to be roughly near a QRS peak. The 
MATLAB function find was used to find these points and set them to be equal to 1.  
%% Thresholds 
thr1= mean(ecg_m1); % FLEXcon threshold 
thr2= mean(ecg_m2); % AgCl threshold 
ecg_p1=zeros(size(ecg_m1)); %vector to store peak approximation, ONLY CONTAINS 1s and 0s 
(FLEXcon) 
ecg_p2=zeros(size(ecg_m2)); %vector to store peak approximation, ONLY CONTAINS 1s and 0s 
(AgCl) 
ecg_p1(find(ecg_m1>=thr1))=1; %data > threshold --> 1, data < threshold --> 0 
ecg_p2(find(ecg_m2>=thr2))=1; 
 
 After this step, the derivative of ecg_p1 and ecg_p2 were used to find the transitional 
points. The index locations of these transitional points were then stored in upindex1, upindex2, 
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downindex1 and downindex2. Upindex contained the locations of the rising edges in the output 
of the moving average filter, whereas downindex contained the falling edge locations. By 
looking at the data that occurs between consecutive rising and falling edges, the peak locations 
could then be accurately determined. 
%% search for peak indices 
a1=diff(ecg_p1); %FLEXcon, derivative of square waveform 
a2=diff(ecg_p2); %AgCl, derivative of square waveform 
  
upindex1=find(a1==1); %find rising edges on square wave, FLEXcon 
upindex2=find(a2==1); %find rising edges on square wave, AgCl 
  
downindex1=find(a1==-1); %find falling edges on square wave, FLEXcon 
downindex2=find(a2==-1); %find falling edges on square wave, FLEXcon 
 
Stage 3 
 To find the exact locations of the peaks, the maximum value between successive rising 
and falling edges were selected in a loop. The instantaneous time where the peak occurs was also 
stored in order to derive the subject’s instantaneous heart rate, which was a crucial component in 
the data analysis. The code to perform this for both channels has been provided as follows. 
Figures 43. & 44. demonstrates that the algorithm successfully picks out the QRS complex peaks 
for both channels. 
%% peak detection, FLEXcon 
prev_peak1=0; 
for i=1:min(length(upindex1),length(downindex1)) 
    [amp1,indtemp1]=max(ecg_hp1(upindex1(i):downindex1(i))); 
    indmax1(i)=indtemp1+upindex1(i)-1; 
    rpeak1(i)=t(indmax1(i)); 
    bpm1(i)=60./(rpeak1(i)-prev_peak1); 
    prev_peak1=rpeak1(i); 
end 
  
%% peak detection, AgCl 
prev_peak2=0; 
for i=1:min(length(upindex2),length(downindex2)) 
    [amp2,indtemp2]=max(ecg_hp2(upindex2(i):downindex2(i))); 
    indmax2(i)=indtemp2+upindex2(i)-1; 
    rpeak2(i)=t(indmax2(i)); 
    bpm2(i)=60./(rpeak2(i)-prev_peak2); 
    prev_peak2=rpeak2(i); 
end 
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Fig. 43. Peak locations for FLEXcon electrodes superposed onto the bandpass filtered ECG 
  
Fig. 44. Peak locations for silver/silver chloride electrodes superposed onto the bandpass filtered ECG 
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FLEXcon and Ag/AgCl Comparison Metrics 
 To compare the FLEXcon electrodes to the Ag/AgCl electrodes, ECG waveforms from 
ten subjects were segmented into data sets that had no noticeable movement artifacts. The 
movement artifacts were found during the heart rate time interval series in where the magnitude 
of this data set would jump from roughly 10
1
 to 10
4
. Considering that a living person with a heart 
rate over 10000 is impossible, these segments were discarded. After peak detection, each peak 
index corresponds to the same time index on a heart rate time interval series. The HR time series 
is computed first by taking the current peak index, and the previous peak index. These indices 
are in time, and taking 60 divided by the difference between these time indices gives the 
instantaneous heart rate in beats per minute. Plotting the magnitude of the heart rate versus time 
gives the representative heart rate time interval plot, shown in Fig. 45. for a 14 second period. In 
blue is the FLEXcon interpolated heart rate, and in red is the Ag/AgCl interpolated heart rate. 
 
Fig. 45. Representative heart rate time interval series 
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 Several statistical computations result from the heart rate time interval series. These 
metrics include the mean and standard deviation of the heart rate for each individual waveform. 
For all ten subjects there are group mean and standard deviations of the individual mean heart 
rates and individual standard deviations of heart rates. The root mean square of successive 
differences (RMSSD) allows the variation in heart rate for all individuals to be found, and the 
correlation coefficient between the FLEXcon and Ag/AgCl waveforms can be derived from the 
RMSSD calculations. The last analysis is of the frequency content in each heart rate interval time 
series. This is accomplished by using a normalized, and windowed, Fourier transform. The 
specific method is the Welch power spectral density algorithm. From this frequency function, the 
sympathetic versus parasympathetic power within the heart rate time interval series can be 
calculated using a composite trapezoidal integration algorithm. Figure 46. depicts the power 
spectral density for the same heart rate time interval series shown in Fig. 45. This plot has a 
normal frequency domain and a logarithmic power of the frequency content in the signal. 
 
Fig. 46. Representation of the Welch power spectral density 
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Table 10 lists the mean heart rate, standard deviation of the heart rate, the low frequency versus 
high frequency mean ratio, and the low frequency versus high frequency standard deviation for 
each Ag/AgCl, small, medium, and large FLEXcon electrode.  
Table 10 Mean and Standard Deviation of Heart Rate Interval Time Series 
 
Small 3.5 cm x 2.5 cm Medium 4 cm x 3 cm Large 5 cm x 4 cm 
AgCl Flexcon AgCl Flexcon AgCl Flexcon 
Mean Heart Rate (BPM) 75.3 74.9 77.6 74.0 73.9 73.9 
Standard Deviation of Heart Rate 
(BPM) 
12.3 13.2 20.8 14.8 9.77 9.60 
Mean LF/HF Ratio 5.06 6.61 8.96 8.73 16.3 16.5 
Standard Deviation of LF/HF Ratio 6.55 9.14 16.7 17.4 26.4 27.4 
 
Each data set corresponds to a three channel set up where one channel is the cumulative 
signal from Ag/AgCl and FLEXcon electrodes, the second channel is the Ag/AgCl electrode 
information, and the third channel is the FLEXcon electrode information. These three data sets 
were simultaneously collected from each subject, and each subject had three separate trials for 
each size of FLEXcon electrodes. Nine data sets were collected from each individual, with 90 
total data sets. Sixty data sets, corresponding to the individual Ag/AgCl and FLEXcon electrode 
waveforms were analyzed, and the cumulative signal was ignored. The data was gathered over a 
six minute period, where the first three minutes are at rest and the second three minutes are with 
movement artifacts. Due to artifacts in the first three minutes, several segments were discarded. 
The total potential time of analysis is 180 minutes. Due to the segmentation of data, the total 
ECG time analyzed is 3991 seconds or 66.52 minutes. In total, only 37% of data was analyzed. 
 The RMSSD values have ten points per electrode size, giving three regression plots 
correlating the FLEXcon and Ag/AgCl RMSSD values between the two electrode types. Figure 
47. depicts the RMSSD trend for the small FLEXcon electrode versus Ag/AgCl, Fig. 48. depicts 
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the RMSSD trend for the medium FLEXcon electrode versus Ag/AgCl, and Fig. 49. depicts the 
RMSSD trend for the large FLEXcon electrode versus Ag/AgCl. 
 
Fig. 47. RMSSD regression for small FLEXcon electrode and Ag/AgCl 
 
Fig. 48. RMSSD regression for medium FLEXcon electrode and Ag/AgCl 
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Figure 49. RMSSD regression for large FLEXcon electrode and Ag/AgCl 
 The correlation coefficient (R) is a result from calculation of the similarities between the 
RMSSD values of each electrode group. These correlation coefficients are essentially computing 
how close the data points in the previous three figures deviate from the line of regression, with a 
range of values between zero and one - where one is an exact correlation. For the small 
FLEXcon electrode versus the Ag/AgCl electrode, the  R value is 0.8887. For the medium 
FLEXcon electrode versus the Ag/AgCl electrode, the R value is 0.6583. For the large FLEXcon 
electrode versus the Ag/AgCl electrode, the R value is 0.9788. From these results, the large 
FLEXcon electrode is most significantly comparable to the industry standard Ag/AgCl hydrogel 
electrode.  
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6. Conclusion 
FLEXcon’s novel ECG electrodes were validated through this project. The dry electrodes are 
comparable to the industry gold standard Ag/AgCl electrodes. The optimal mixture to fabricate 
electrodes was determined to be 10% carbon combined with 90% PSA. This resulted in the 
lowest post-activation impedance.  FLEXcon’s electrodes are cost effective because they can be 
produced at a significantly cheaper cost than Ag/AgCl electrodes since carbon is cheaper than 
silver. These dry electrodes need to be activated prior to use in order to reduce the impedance.  
The team found the optimal activation parameters to be 200V, 100mA current and a 100ms 
discharge time. Further verification included testing the electrodes on human subjects using 
holter monitors, and comparing their performance to standard Ag/AgCl electrodes.  Statistical 
analysis on the data collected proves that there is no statistical significant difference in signal 
quality between FLEXcon electrodes and Ag/AgCl electrodes. FLEXcon’s electrodes address 
two of Ag/AgCl electrode’s issues: dehydration and cost.  They are cheaper, and are not 
dehydrated because they are dry electrodes.  While addressing these problems, FLEXcon’s novel 
electrodes produce ECG signal quality comparable to that of Ag/AgCl electrodes. 
In the future, further comparisons can be made between FLEXcon’s electrodes and Ag/AgCl 
electrodes.  The electrodes should be tested on human subjects submerged in water to see if this 
affects the signal quality.  A similar condition to be tested is perspiration.  The electrodes could 
be applied to the skin while the subject is sweating, which will determine if perspiration causes 
any changes in signal quality.   
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Appendix  A 
THINflex® PP 075 H CLEAR A-208 TRACrite™ 100 Technical Data 
 
Fig. 50. THINflex® PP 075 H CLEAR A-208 TRACrite™ 100 Table 
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Appendix B 
Precision LC Meter 7600 Plus®, IET Labs Inc.™ Performance Sheet 
 
Fig. 51. Precision LCR Meter 7600 Plus by IET Labs, Inc. 
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Appendix C 
 
Fig. 52. Hioki IM 3570 Impedance Analyzer Data Sheet 
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Appendix  D 
MATLAB Statistical Analysis 
The statistical results are generated by the following code listing in MATLAB2012A: 
%MATLAB DATA ANALYSIS% 
%%Function to calculate Gaussian Distribution%% 
  
function f= Gaussian(x, mu, sigma) 
  
exponent= -0.5*((x-mu)/sigma).^2; 
denom= sigma*sqrt(2*pi); 
  
f= exp(exponent)./denom; 
 
%% OUTLIER REMOVAL 
%% 
%%Reading the data, calculation of total sum 
pre_8= xlsread('Test_Results_8_10_12.xlsx', 1, 'C2:C31'); 
pre_10= xlsread('Test_Results_8_10_12.xlsx', 1, 'E2:E31'); 
pre_12= xlsread('Test_Results_8_10_12.xlsx', 1, 'G2:G31'); 
post_8= xlsread('Test_Results_8_10_12.xlsx', 1, 'D2:D31'); 
post_10= xlsread('Test_Results_8_10_12.xlsx', 1, 'F2:F31'); 
post_12= xlsread('Test_Results_8_10_12.xlsx', 1, 'H2:H31'); 
  
%% Find first and third quartiles, and Interquartile range 
  
pre8_Q1= median(pre_8(find(pre_8<median(pre_8)))); 
pre8_Q3= median(pre_8(find(pre_8>median(pre_8)))); 
IQR_pre8=  pre8_Q3 - pre8_Q1; 
  
post8_Q1= median(post_8(find(post_8<median(post_8)))); 
post8_Q3= median(post_8(find(post_8>median(post_8)))); 
IQR_post8=  post8_Q3 - post8_Q1; 
  
pre10_Q1= median(pre_10(find(pre_10<median(pre_10)))); 
pre10_Q3= median(pre_10(find(pre_10>median(pre_10)))); 
IQR_pre10=  pre10_Q3 - pre10_Q1; 
  
post10_Q1= median(post_10(find(post_10<median(post_10)))); 
post10_Q3= median(post_10(find(post_10>median(post_10)))); 
IQR_post10=  post10_Q3 - post10_Q1; 
  
pre12_Q1= median(pre_12(find(pre_12<median(pre_12)))); 
pre12_Q3= median(pre_12(find(pre_12>median(pre_12)))); 
IQR_pre12=  pre12_Q3 - pre12_Q1; 
  
post12_Q1= median(post_12(find(post_12<median(post_12)))); 
post12_Q3= median(post_12(find(post_12>median(post_12)))); 
IQR_post12=  post12_Q3 - post12_Q1; 
  
%once we have the interquartile ranges, we need to multiply by 1.5 and 
%subtract that from the lower quartile and add it to the upper quartile. 
%Any data point outside this will be an outlier 
  
%% OUTLIER REMOVAL FROM THE DATA 
  
m=1.5; 
  
%Pre 8 
pre8_upper= IQR_pre8*(m)+pre8_Q3; 
pre8_lower= pre8_Q1- IQR_pre8*(m); 
  
count=30; 
  
for i=1:27 
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    if pre_8(i)>pre8_upper 
        pre_8(i)= []; 
        count= count-1; 
    elseif pre_8(i)<pre8_lower 
        pre_8(i)= []; 
        count= count-1; 
    end 
end 
  
%Post 8 
post8_upper= IQR_post8*(m)+ post8_Q3; 
post8_lower= post8_Q1- IQR_post8*(m); 
  
count=30; 
  
for j=1:27 
     
    if post_8(j)>post8_upper 
        post_8(j)= []; 
        count= count-1; 
    elseif post_8(j)<post8_lower 
        post_8(j)= []; 
        count= count-1; 
    end 
end 
  
%Pre 10 
pre10_upper= IQR_pre10*(m)+pre10_Q3; 
pre10_lower= pre10_Q1- IQR_pre10*(m); 
  
count=30; 
  
for k=1:27 
     
    if pre_10(k)>pre10_upper 
        pre_10(k)= []; 
        count= count-1; 
    elseif pre_10(k)<pre10_lower 
        pre_10(k)= []; 
        count= count-1; 
    end 
end 
  
%Post 10 
post10_upper= IQR_post10*(m)+ post10_Q3; 
post10_lower= post10_Q1- IQR_post10*(m); 
  
count=30; 
  
for l=1:28 
     
    if post_10(l)>post10_upper 
        post_10(l)= []; 
        count= count-1; 
    elseif post_10(l)<post10_lower 
        post_10(l)= []; 
        count= count-1; 
    end 
end 
  
%Pre 12 
pre12_upper= IQR_pre12*(m)+pre12_Q3; 
pre12_lower= pre12_Q1- IQR_pre12*(m); 
  
count=30; 
  
for k=1:count 
     
    if pre_12(k)>pre12_upper 
        pre_12(k)= []; 
        count= count-1; 
 OPTIMIZING NOVEL ECG ELECTRODES  76 
 
 
    elseif pre_12(k)<pre12_lower 
        pre_12(k)= []; 
        count= count-1; 
    end 
end 
  
%Post 12 
post12_upper= IQR_post12*(m)+ post12_Q3; 
post12_lower= post12_Q1- IQR_post12*(m); 
  
count=30; 
  
for l=1:28 
     
    if post_12(l)>post12_upper 
        post_12(l)= []; 
        count= count-1; 
    elseif post_12(l)<post12_lower 
        post_12(l)= []; 
        count= count-1; 
    end 
end 
  
%% Calculate new averages, stdev and gaussian without outliers 
  
%Pre 8 
avg_8pre= mean(pre_8); 
stdev_8pre= std(pre_8); 
pre_8gauss = Gaussian(pre_8, avg_8pre, stdev_8pre); 
figure(1); 
subplot(2,1,1); 
plot(pre_8, pre_8gauss, '.'); 
grid on; 
title('Gaussian distribution for pre activation impedance, 8%'); 
xlabel('impedance/Mega Ohms'); 
ylabel('Gaussian distribution'); 
  
%post 8 
avg_8post= mean(post_8); 
stdev_8post= std(post_8); 
post_8gauss = Gaussian(post_8, avg_8post, stdev_8post); 
subplot(2,1,2); 
plot(post_8, post_8gauss, '.'); 
grid on; 
title('Gaussian distribution for post activation impedance, 8%'); 
xlabel('impedance/Ohms'); 
ylabel('Gaussian distribution'); 
             
%Pre 10 
avg_10pre= mean(pre_10); 
stdev_10pre= std(pre_10); 
pre_10gauss = Gaussian(pre_10, avg_10pre, stdev_10pre); 
figure(2) 
subplot(2,1,1); 
plot(pre_10, pre_10gauss, '.'); 
grid on; 
title('Gaussian distribution for pre activation impedance, 10%'); 
xlabel('impedance/Mega Ohms'); 
ylabel('Gaussian distribution'); 
  
%post 10 
avg_10post= mean(post_10); 
stdev_10post= std(post_10); 
post_10gauss = Gaussian(post_10, avg_10post, stdev_10post); 
subplot(2,1,2); 
plot(post_10, post_10gauss, '.'); 
grid on; 
title('Gaussian distribution for post activation impedance, 10%'); 
xlabel('impedance/Ohms'); 
ylabel('Gaussian distribution'); 
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%Pre 12 
avg_12pre= mean(pre_12); 
stdev_12pre= std(pre_12); 
pre_12gauss = Gaussian(pre_12, avg_12pre, stdev_12pre); 
figure(3) 
subplot(2,1,1); 
plot(pre_12, pre_12gauss, '.'); 
grid on; 
title('Gaussian distribution for pre activation impedance, 12%'); 
xlabel('impedance/Mega Ohms'); 
ylabel('Gaussian distribution'); 
  
%post 12 
avg_12post= mean(post_12); 
stdev_12post= std(post_12); 
post_12gauss = Gaussian(post_12, avg_12post, stdev_12post); 
subplot(2,1,2); 
plot(post_12, post_12gauss, '.'); 
grid on; 
title('Gaussian distribution for post activation impedance, 12%'); 
xlabel('impedance/Ohms'); 
ylabel('Gaussian distribution'); 
  
%% T Tests for distributions without outliers 
 
%Unpaired t tests 
  
%8% 
alpha=0.01;     % 95% significance level 
  
[h_8pre,p_8pre]= ttest(pre_8, alpha); 
[h_8post,p_8post]= ttest(post_8, alpha); 
  
%10% 
[h_10pre,p_10pre]= ttest(pre_10, alpha); 
[h_10post,p_10post]= ttest(post_10, alpha); 
  
%12% 
[h_12pre,p_12pre]= ttest(pre_12, alpha); 
[h_12post,p_12post]= ttest(post_12, alpha); 
  
%paired t tests to pick between 8%, 10% and 12% 
[h_10and12post, p_10and12post] = ttest2(post_10, post_12); 
[h_10and8post, p_10and8post] = ttest2(post_10, post_8); 
[h_12and8post, p_12and8post] = ttest2(post_12, post_8); 
  
[h_10and12pre, p_10and12pre] = ttest2(pre_10, pre_12); 
[h_10and8pre, p_10and8pre] = ttest2(pre_10, pre_8); 
[h_12and8pre, p_12and8pre] = ttest2(pre_12, pre_8); 
 
%we get an h value of 1 in the above lines, rejecting the null hypothesis 
%that the two vectors have equal means. Since the sample average was the 
%lowest for 10% and in theory it should stick to the patient skin better 
%with 10%,we can select 10% as our preferred carbon level. 
  
 
MATLAB Mean Impedance vs. Power Plots 
clc; clear all; close all; 
data=xlsread('data.xlsx'); 
  
%.1uf 
voltage=[200 120 75 45 20 5]; 
current=[1e-3 2e-3 5e-3 10e-3 20e-3 50e-3 100e-3]; 
  
figure(1) 
grid on 
hold on 
xlabel('Power') 
ylabel('Impedance') 
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title('0.1uF Activation Impedance') 
n=1; 
for j=1:1:7 
    for i=1:1:6 
        power(i,j)=voltage(i)*current(j); 
        plot(power(i,j),data(n,3),'o'); 
        n=n+1; 
    end 
end 
  
figure(2) 
grid on 
hold on 
xlabel('Power') 
ylabel('Impedance') 
title('1.0uF Activation Impedance') 
for j=1:1:7 
    for i=1:1:6 
        power(i,j)=voltage(i)*current(j); 
        plot(power(i,j),data(n,3),'o'); 
        n=n+1; 
    end 
end 
  
figure(3) 
grid on 
hold on 
xlabel('Power') 
ylabel('Impedance') 
title('10.0uF Activation Impedance') 
for j=1:1:6 
    if i==6 
        for i=1:1:3 
        power(i,j)=voltage(i)*current(j); 
        plot(power(i,j),data(n,3),'o'); 
        n=n+1; 
        end 
    else 
        for i=1:1:6 
        power(i,j)=voltage(i)*current(j); 
        plot(power(i,j),data(n,3),'o'); 
        n=n+1; 
        end 
    end 
end 
 
MATLAB ECG and FFT Waveform Plots 
clc; clear all; close all; 
  
agcl_rest=xlsread('agcl_electrode_rest.xls'); 
agcl_rest_fft=abs(fft(agcl_rest(:,2))); 
agcl_rest_fft=agcl_rest_fft./max(max(agcl_rest_fft)); 
  
agcl_mov=xlsread('agcl_electrode_movement.xls'); 
agcl_mov_fft=abs(fft(agcl_mov(:,2))); 
agcl_mov_fft=agcl_mov_fft./max(max(agcl_mov_fft)); 
  
small_rest=xlsread('carbon_electrode_small_rest.xls'); 
small_rest_fft=abs(fft(small_rest(:,2))); 
small_rest_fft=small_rest_fft./max(max(small_rest_fft)); 
  
small_mov=xlsread('carbon_electrode_small_movement.xls'); 
small_mov_fft=abs(fft(small_mov(:,2))); 
small_mov_fft=small_mov_fft./max(max(small_mov_fft)); 
  
medium_rest=xlsread('carbon_electrode_medium_rest.xls'); 
medium_rest_fft=abs(fft(medium_rest(:,2))); 
medium_rest_fft=medium_rest_fft./max(max(medium_rest_fft)); 
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medium_mov=xlsread('carbon_electrode_medium_movement.xls'); 
medium_mov_fft=abs(fft(medium_mov(:,2))); 
medium_mov_fft=medium_mov_fft./max(max(medium_mov_fft)); 
  
large_rest=xlsread('carbon_electrode_large_rest.xls'); 
large_rest_fft=abs(fft(large_rest(:,2))); 
large_rest_fft=large_rest_fft./max(max(large_rest_fft)); 
  
large_mov=xlsread('carbon_electrode_large_movement.xls'); 
large_mov_fft=abs(fft(large_mov(:,2))); 
large_mov_fft=large_mov_fft./max(max(large_mov_fft)); 
  
f=0:1000/(length(agcl_rest_fft)-1):1000; 
  
figure(1) 
plot(large_mov(:,1),large_mov(:,2)) 
title('Movement ECG Waveform of Large FLEXcon Electrodes') 
xlabel('Time [s]') 
ylabel('Voltage [V]') 
grid on 
  
figure(2) 
plot(f,large_mov_fft) 
title('Fast Fourier Transform of Large FLEXcon Movement ECG Waveform') 
xlabel('Frequency [Hz]') 
ylabel('Normalized Magnitude') 
axis([0 100 0 1]) 
grid on 
 
MATLAB Impedance vs. Frequency Sweep Plots 
clc; clear all; close all; 
  
csv_names={'130219105255.csv', 
           '130219105447.csv', 
           '130219105701.csv', 
           '130219105913.csv', 
           '130219110043.csv', 
           '130219110222.csv', 
           '130219110341.csv', 
           '130219110500.csv', 
           '130219110620.csv', 
           '130219110744.csv'}; 
  
for i=1:1:length(csv_names) 
    l_raw(:,i)=textread(csv_names{i},'%q'); 
    l_clean(:,i)=l_raw(36:434,i); 
    lz_cell(:,i)=l_clean(3:4:399,i); 
    lz_vec(:,i)=cellfun(@str2num,lz_cell(:,i)); 
end 
  
f=l_clean(2:4:398,1); 
f=cellfun(@str2num,f); 
  
for i=1:1:length(lz_vec) 
    m(i)=mean(lz_vec(i,1:1:2));  
end 
  
for i=1:1:length(lz_vec) 
    eb(i)=std(lz_vec(i,1:1:length(csv_names))); 
end 
  
figure(1) 
loglog(f,m,'x','LineWidth',2) 
hold on 
loglog(f,m,'-') 
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for i=1:1:length(lz_vec) 
    errorbar(f(i),m(i),eb(i),'r') 
end 
xlabel('Frequency [Hz]') 
ylabel('Impedance [Z]') 
title('Impedance vs. Frequency of Large Electrodes, with Standard Error') 
grid on 
axis([min(f)*.90 max(f)*1.10 (min(eb)+min(m))*.95 (max(eb)+max(m))*1.05]); 
  
figure(2) 
plot(f,m,'x','LineWidth',2) 
hold on 
plot(f,m,'-') 
  
for i=1:1:length(lz_vec) 
    errorbar(f(i),m(i),eb(i),'r') 
end 
  
xlabel('Frequency [Hz]') 
ylabel('Impedance [Z]') 
title('Impedance vs. Frequency of Large Electrodes, with Standard Error') 
grid on 
axis([min(f)*.90 max(f)*1.10 (min(eb)+min(m))*.95 (max(eb)+max(m))*1.05]); 
 
Peak Detection Algorithm 
clc; clear all; close all; 
 
%% Read data 
%ecg=dlmread('at_rest_1.txt'); 
ecg= csvread('32223.csv'); 
% ecg1= ecg(((15*180):(40*180)),3)./1000;   %FLEXcon electrode data 
% ecg2= ecg(((15*180):(40*180)),2)./1000;   %silver chloride data 
% ecg1 =[ecg1; (ecg((47*180):(172*180),3)./1000)]; 
% ecg2 =[ecg2; (ecg((47*180):(172*180),2)./1000)]; 
ecg1= ecg(1:32400,3)./1000;   %FLEXcon electrode data 
ecg2= ecg(1:32400,2)./1000;   %silver chloride data 
% All flexcon variables end with 1, silver with 2 % 
 
 
%% Sampling frequency, time vector 
Fs=180; %sampling frequency of Rozinn holter monitor    
dt=1/Fs; %time increment 
duration=length(ecg1)*dt;   %length of data   
t=0:dt:duration-dt; %time vector 
t=t';   %transpose time vector for detrending 
 
 
%% Detrending solution 
N=180;  %length for detrending solution, 1 second long 
for i=1:N:length(ecg1)-N-1 
    p1=polyfit(t(i:(i+N-1)),ecg1(i:(i+N-1)),1); %generate coefficients for 
polynomial for FLEXcon 
    yfit1=polyval(p1,t(i:(i+N-1))); %create data set to be subtracted from raw ECG 
data, FLEXcon 
    p2=polyfit(t(i:(i+N-1)),ecg2(i:(i+N-1)),1);%generate coefficients for 
polynomial for silver chloride 
    yfit2=polyval(p2,t(i:(i+N-1)));%create data set to be subtracted from raw ECG 
data, silver chloride 
    for j=1:N 
        ecg1(i+j-1)=ecg1(i+j-1)-yfit1(j);   %detrend the raw data, FLEXcon 
        ecg2(i+j-1)=ecg2(i+j-1)-yfit2(j);   %detrend the raw data, silver chloride 
    end 
end 
 
%% Correction for DC noise level for threshold 
ecg1=ecg1-mean(ecg1);   %zeros the ECG essentially 
ecg2=ecg2-mean(ecg2);   %silver 
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%% Raw data 
figure(1) 
plot(t,ecg1); 
%axis([5000/180 6000/180 -300 900]) 
grid on; hold on; 
plot(t,ecg2, 'r-.'); 
axis([5000/180 6000/180 -1 3]) 
xlabel('Time [s]');    
ylabel('Voltage [V]');     
title('Raw ECG Waveform'); 
legend('FLEXcon','AgCl'); 
 
%% Lowpass filtering 
bl=[1 0 0 0 0 0 -2 0 0 0 0 0 1]; 
al=[1 -2 1]; 
ecg_lp1=filter(bl,al,ecg1); % Lowpass filter FLEXcon data 
ecg_lp2=filter(bl,al,ecg2); % LP filter silver data 
 
%% Highpass filtering 
bh=[-1 zeros(1,15) 32 zeros(1,15) 1]; 
ah=[1 1]; 
ecg_hp1=filter(bh,ah,ecg_lp1);  %HP filter FLEXcon 
ecg_hp2=filter(bh,ah,ecg_lp2);  %HP filter AgCl 
 
%% Derivative filtering, squaring 
bd=(1/8)*[2 1 0 -1 -2]; 
ad=[1]; 
ecg_der1=filter(bd,ad, ecg_hp1);    %derivative filter FLEXcon 
ecg_der2=filter(bd,ad, ecg_hp2);    %derivative filter AgCl 
 
ecg_sq1=(ecg_der1).^2; 
ecg_sq2=(ecg_der2).^2; 
 
%% Moving average filtering 
N=30;   %length of MA filter  
bm=(1/N)*[ones(1,N)]; 
am=[1]; 
ecg_m1=filter(bm,am,ecg_sq1);   %MA filter FLEXcon 
ecg_m2=filter(bm,am,ecg_sq2);   %MA filter AgCl 
 
figure(2) 
plot(t,ecg_m1); %FLEXcon MA output for thresholding 
 
figure(3) 
plot(t,ecg_m2); %AgCl thresholding 
 
%% Thresholds 
%thr1=10; % FLEXcon threshold 
%thr2=10; % AgCl threshold 
 
thr1= mean(ecg_m1); 
thr2= mean(ecg_m2); 
 
ecg_p1=zeros(size(ecg_m1)); %vector to store peak approximation, ONLY CONTAINS 1s and 0s 
(FLEXcon) 
ecg_p2=zeros(size(ecg_m2)); %vector to store peak approximation, ONLY CONTAINS 1s and 0s 
(AgCl) 
 
ecg_p1(find(ecg_m1>=thr1))=1;   %data > threshold --> 1, data < threshold --> 0 
ecg_p2(find(ecg_m2>=thr2))=1; 
 
figure(2) 
plot(t,ecg_p1) 
hold on; grid on; 
plot(t,ecg_p2, 'r-.'); 
xlabel('Time [s]'); 
ylabel('Amplitude [filt V]'); 
title('Square ECG Peak Waveform'); 
legend('FLEXcon','AgCl'); 
 
%% search for peak indices 
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a1=diff(ecg_p1); %FLEXcon, derivative of square waveform 
a2=diff(ecg_p2); %AgCl, derivative of square waveform 
 
upindex1=find(a1==1); %find rising edges on square wave, FLEXcon 
upindex2=find(a2==1); %find rising edges on square wave, AgCl 
 
downindex1=find(a1==-1); %find falling edges on square wave, FLEXcon 
downindex2=find(a2==-1); %find falling edges on square wave, FLEXcon 
 
%% peak detection, FLEXcon 
prev_peak1=0; 
for i=1:min(length(upindex1),length(downindex1)) 
    [amp1,indtemp1]=max(ecg_hp1(upindex1(i):downindex1(i))); 
    indmax1(i)=indtemp1+upindex1(i)-1; 
    rpeak1(i)=t(indmax1(i)); 
    bpm1(i)=60./(rpeak1(i)-prev_peak1); 
    prev_peak1=rpeak1(i); 
end 
 
%% peak detection, AgCl 
prev_peak2=0; 
for i=1:min(length(upindex2),length(downindex2)) 
    [amp2,indtemp2]=max(ecg_hp2(upindex2(i):downindex2(i))); 
    indmax2(i)=indtemp2+upindex2(i)-1; 
    rpeak2(i)=t(indmax2(i)); 
    bpm2(i)=60./(rpeak2(i)-prev_peak2); 
    prev_peak2=rpeak2(i); 
end 
 
%% PD plots 
figure(4) 
plot(t, ecg_hp1) 
hold on; grid on; 
plot(rpeak1, ecg_hp1(indmax1),'or'); 
xlabel('Time (s)');ylabel('Voltage after BP filtering (V)'); 
title('FLEXcon ECG Waveform') 
axis([5000/180 6000/180 -300 900]) 
 
figure(5) 
plot(t, ecg_hp2,'k') 
hold on; grid on; 
plot(rpeak2, ecg_hp2(indmax2),'xr'); 
xlabel('Time (s)');ylabel('Voltage after BP filtering (V)'); 
title('Ag/AgCl ECG Waveform') 
axis([5000/180 6000/180 -300 900]) 
 
%% R-R intervals, cubic interpolation 
RR1=diff(rpeak1); 
RR2=diff(rpeak2); 
 
time_lr1=zeros(1,length(RR1)); 
time_lr2=zeros(1,length(RR2)); 
 
time_lr1(1)=0; 
for i=2:length(RR1) 
    time_lr1(i)=sum(RR1(1:i-1)); 
end 
 
time_lr2(1)=0; 
for i=2:length(RR2) 
    time_lr2(i)=sum(RR2(1:i-1)); 
end 
 
timeRR1=0:1/4:sum(RR1)-1/4; 
timeRR2=0:1/4:sum(RR2)-1/4; 
 
ys1=interp1(time_lr1,bpm1(1:length(time_lr1)),timeRR1,'spline'); 
ys2=interp1(time_lr2,bpm2(1:length(time_lr2)),timeRR2,'spline'); 
 
figure(6) 
plot(timeRR1,ys1) 
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grid on; hold on; 
plot(timeRR2,ys2,'r.-') 
xlabel('Time [s]');  
ylabel('Beats per Minute'); 
title('Cubic Interpolation of HR Time Intervals'); 
legend('FLEXcon cubic interpolation','AgCl cubic interpolation'); 
 
ys1= ys1-mean(ys1); 
ys2= ys2-mean(ys2); 
 
 
%% Power Spectral Density (PSD) 
[psd_cubic1,f]=pwelch(ys1,length(ys1),[],512,4); 
[psd_cubic2,f]=pwelch(ys2,length(ys2),[],512,4); % 
%psd_linear=(abs(psd_linear)).^2; 
psd_cubic1=(abs(psd_cubic1)).^2; 
psd_cubic2=(abs(psd_cubic2)).^2; 
%figure 
%plot(f,psd_linear) 
%xlim([0 0.5]) 
figure(7) 
plot(f,psd_cubic1, 'LineWidth',3) 
xlim([0 0.5]) 
grid on; hold on; 
plot(f,psd_cubic2, 'r-.','LineWidth',3) 
xlabel('Frequency in Hz'); 
ylabel('Power'); 
title('Representative Power Spectral Density Comparison'); 
legend('FLEXcon Electrodes','Ag/AgCl Electrodes') 
 
%% LF/HF 
 
low_index=find(f>=0.04 & f<=0.15); 
low_f=f(low_index); 
low_psd_cubic1=psd_cubic1(low_index); 
low_psd_cubic2=psd_cubic2(low_index); 
 
high_index= find(f>=0.15 & f<=0.4); 
high_f=f(high_index); 
high_psd_cubic1=psd_cubic1(high_index); 
high_psd_cubic2=psd_cubic2(high_index); 
 
LF1= sum(low_psd_cubic1); 
LF2= sum(low_psd_cubic2); 
 
HF1= sum(high_psd_cubic1); 
HF2= sum(high_psd_cubic2); 
 
LFHF1= LF1/HF1 
LFHF2= LF2/HF2 
 
%% Mean, Standard Deviation, RMSSD, SDNN 
 
mean_bpm1= mean(bpm1) 
mean_bpm2= mean(bpm2) 
 
std_bpm1= std(bpm1) 
std_bpm2= std(bpm2) 
 
sumSD1=0; 
sumSD2=0; 
 
for i=2:1:length(RR1) 
    sumSD1= sumSD1+ ((RR1(i)-RR1(i-1))^2); 
end 
 
for i=2:1:length(RR2) 
    sumSD2= sumSD2+ ((RR2(i)-RR2(i-1))^2); 
end 
 
RMSSD1= sqrt(sumSD1./(length(RR1)-1)) 
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RMSSD2= sqrt(sumSD2./(length(RR2)-1)) 
 
SDNN1= std(RR1) 
SDNN2= std(RR2) 
 
temp=[LFHF1 mean_bpm1 std_bpm1 RMSSD1 SDNN1; 
      LFHF2 mean_bpm2 std_bpm2 RMSSD2 SDNN2] 
 
 RMSSD Analysis Algorithm 
%% RMSSD DISTRIBUTION 
clc; clear all; close all; 
data=xlsread('electrode_comparison.xlsx'); 
 
smFL=data(1:6:60,5); 
smAg=data(2:6:60,5); 
rmssd_mean_smFL=mean(smFL); 
rmssd_mean_smAg=mean(smAg); 
 
figure(1) 
scatter(smAg, smFL); 
xlabel('RMSSD of AgCl ECG'); 
ylabel('RMSSD of FLEXcon small ECG'); 
title('RMSSD observed on FLEXcon small against AgCl'); 
grid on; 
legend('RMSSD distribution'); 
axis([0 0.5 0 0.5]) 
hold on 
p=polyfit(smAg,smFL,1); 
yfit=polyval(p,0:0.01:1.5); 
plot(0:0.01:1.5,yfit,'r') 
 
medFL=data(3:6:60,5); 
medAg=data(4:6:60,5); 
rmssd_mean_medFL=mean(medFL); 
rmssd_mean_medAg=mean(medAg); 
 
figure(2) 
scatter(medAg, medFL); 
xlabel('RMSSD of AgCl ECG'); 
ylabel('RMSSD of FLEXcon medium ECG'); 
title('RMSSD observed on FLEXcon medium against AgCl'); 
grid on; 
legend('RMSSD distribution'); 
axis([0 0.5 0 0.5]) 
hold on 
p=polyfit(medAg,medFL,1); 
yfit=polyval(p,0:0.01:1.5); 
plot(0:0.01:1.5,yfit,'r') 
active.BackgroundColor = [0 1 0]; 
active.Enable = 'on'; 
 
 
lFL=data(5:6:60,5); 
lAg=data(6:6:60,5); 
rmssd_mean_lFL=mean(lFL); 
rmssd_mean_lAg=mean(lAg); 
 
figure(3) 
scatter(lAg, lFL); 
xlabel('RMSSD of AgCl ECG'); 
ylabel('RMSSD of FLEXcon large ECG'); 
title('RMSSD observed on FLEXcon large against AgCl'); 
grid on; 
legend('RMSSD distribution'); 
axis([0 0.5 0 0.5]) 
hold on 
p=polyfit(lAg,lFL,1); 
yfit=polyval(p,0:0.01:1.5); 
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plot(0:0.01:1.5,yfit,'r') 
 
%% t test on RMSSD 
 
[H_sm,P_sm,CI_sm]= ttest2(smFL,smAg,0.05,'both') 
 
[H_med,P_med,CI_med]= ttest2(medFL,medAg,0.05,'both') 
 
[H_lar,P_lar,CI_lar]= ttest2(lFL,lAg,0.05,'both') 
 
mean_FLsm= mean(data(1:6:60,3)); 
std_FLsm= mean(data(1:6:60,4)); 
 
mean_FLmed= mean(data(3:6:60,3)); 
std_FLmed= mean(data(3:6:60,4)); 
 
mean_FLlar= mean(data(5:6:60,3)); 
std_FLlar= mean(data(5:6:60,4)); 
 
mean_Agsm= mean(data(2:6:60,3)); 
std_Agsm= mean(data(2:6:60,4)); 
 
mean_Agmed= mean(data(4:6:60,3)); 
std_Agmed= mean(data(4:6:60,4)); 
 
mean_Aglar= mean(data(6:6:60,3)); 
std_Aglar= mean(data(6:6:60,4)); 
 
temp=[mean_FLsm mean_Agsm mean_FLmed mean_Agmed mean_FLlar mean_Aglar; 
      std_FLsm std_Agsm std_FLmed std_Agmed std_FLlar std_Aglar]; 
   
rsm= corrcoef(smFL,smAg); 
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Appendix  E 
Glossary of Statistical Terms and Tests 
 Population: Every object in the data collected. 
 Sample: A subset of the population. 
 Mean: A measure of central tendency, the mean is the average value of a set of numbers. 
For the purposes of this project, the mean is used to refer to the mean of the sample, 
denoted by the symbol   . 
 Median: Another measure of central tendency, the median is the number separating the 
higher half of a dataset from the lower half of the dataset. It can be found by rearranging 
the sample from its lowest value to its highest value. By median, this project will refer to 
the median of the sample. 
 Standard Deviation: It is a measure of the dispersion from the mean in the data and 
commonly denoted by the letter σ. In a normal (Gaussian) distribution, 68.2% of the data 
collected lies within the range of   ± σ. Therefore, a high standard deviation means that 
there exists high variability in the data. 
 Gaussian distribution: It is a continuous probability distribution which has a 
characteristic bell-shaped probability density curve. 
 First Quartile (Q1): Like the median, the first quartile separates the lowest 25% of the 
sample from the highest 75%. 
 Third Quartile (Q3): The third quartile separates the highest 25% of the sample from 
the lowest 75%. 
 Interquartile Range (IQR): The interquartile range is the difference between the third 
quartile and the first quartile. 
 Outlier: An outlier is a single object/data point in the sample which is far removed from 
the mean of the sample. The outliers in a sample can be estimated using the first quartile, 
the third quartile and the interquartile range. No strict statistical definition exists for 
finding the outliers in a dataset. For the purposes of this project, any data point that was 
lower than Q1- 1.5*(IQR) and higher than Q3 + 1.5*(IQR) were picked as outliers and 
removed from analysis. 
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Appendix F 
Participant Consent Form 
Study Protocol:  
Non-Invasive Comparison of Novel FLEXcon Electrodes vs. Standard Ag-AgCl Electrodes. 
 
Step 1: Give consent form to volunteer for reading and signature. 
 
Step 2: Apply monitoring devices. 
1. Wipe skin under left and right collar bone with alcohol swabs. 
2. 3-lead Ag/AgCl ECG electrodes over the thorax and limbs. 
a. White lead  Right collar bone 
b. Black lead  Left collar bone 
c. Red lead  Left lower abdomen 
3. Connect leads to the Wireless Holter Monitor, worn via a strap around the waist. 
 
Step 3: Turn on equipment and test all software. 
1. Turn on Holter Monitor and make sure it is working properly. 
2. Turn on PowerLab A/D converter and plug USB into computer. 
3. Start LabChart Data Acquisition Software. 
a. Set up ECG. 
b. Set up sampling rate to 500 Hz. 
 
Step 4: Experiments. 
1. Relaxed Electrocardiogram. 
a. Seat position. 
i. Ask volunteer to take seat in a laboratory chair. 
ii. Make sure volunteer is comfortable. 
iii. Make sure all the sensors are placed in comfortable and secure positions. 
iv. Begin waveform recording in LabChart. 
v. Record ECG for 3 minutes. 
vi. Save the recording using the file naming protocol explained below. 
 
Step 5: Removing monitoring devices. 
1. At the conclusion of the ECG measurement, remove ECG electrodes, and Holter Monitors.  
Help in the removing and cleaning process as needed.  
2. Repeat Steps 1-5 using the small, medium, and large FLEXcon electrodes. 
 
Step 6: Ensure subject safety. 
1. Ask the subject if they are experiencing any allergic skin irritation due to the acrylic, and 
record their answer. 
 
File naming protocol. 
Save the corresponding record files according to the following formula: 
‘DATE_ORDINAL_ELECTRODE.extension’ 
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DATE = MMDDYYYY in numbers. 
ORDINAL = ordinal number of subject in that corresponding date.  
ELECTRODE = ‘FLEXcon’ or ‘Ag/AgCl’ 
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Appendix G 
Stage 1 Data Set 
 
Table 11 Complete Mean & STD Table for Stage 3 Impedance Data Set 
Parameters Pre-Activation [Ω] Post-Activation [Ω] 
Voltage Capacitance Current MEAN STD MEAN STD 
200V .1µF 1mA 14636400 1520607 1653824 3407938 
120V .1µF 1mA 2198974 577531.6 1173874 1239023 
75V .1µF 1mA 2199626 237426.1 611177.8 997353.5 
45V .1µF 1mA 2443651 207027.3 1590801 1140364 
20V .1µF 1mA 2165919 786507.4 1633331 847051.9 
5V .1µF 1mA 6360598 8862035 1477895 1099961 
200V .1µF 2mA 20423840 4184816 47500.61 49270.68 
120V .1µF 2mA 18319196 10762102 5567859 12322094 
75V .1µF 2mA 21228380 3771418 10665030 14057955 
45V .1µF 2mA 16198315 9971588 16397071 9744139 
20V .1µF 2mA 21755020 4128219 22370860 5039054 
5V .1µF 2mA 23073880 6988715 13413121 12437663 
200V .1µF 5mA 16443560 6663539 12217.84 7905.9 
120V .1µF 5mA 17338540 9042852 10639719 14614636 
75V .1µF 5mA 21273900 4090344 13936858 12792668 
45V .1µF 5mA 18160430 9691436 18471767 10901223 
20V .1µF 5mA 22170840 732922.3 22989980 1083008 
5V .1µF 5mA 21270080 2059371 17620112 9963031 
200V .1µF 10mA 25713840 5408599 12215105 16639228 
120V .1µF 10mA 23572240 2186583 18866309 10797970 
75V .1µF 10mA 20302260 3092992 9574641 13082697 
45V .1µF 10mA 18186320 1638069 8201691 11225125 
20V .1µF 10mA 21989540 3009596 22968180 3418870 
5V .1µF 10mA 21648500 3514644 18094921 10158022 
200V .1µF 20mA 18835105 3706363 3678.83 1875.343 
120V .1µF 20mA 21513340 3324093 5310927 11869314 
75V .1µF 20mA 21073900 3458819 18358739 10300525 
45V .1µF 20mA 22893120 3298875 23050260 3183548 
20V .1µF 20mA 23185740 3126309 22940080 3150006 
5V .1µF 20mA 21284980 584814.2 12902898 9761501 
200V .1µF 50mA 20234640 1898718 4729812 10568322 
120V .1µF 50mA 19016740 2901618 8169034 11203827 
75V .1µF 50mA 21290060 3779017 17936729 10597021 
45V .1µF 50mA 24101740 2521022 24797640 4169780 
20V .1µF 50mA 22368240 1857666 22963560 1679374 
5V .1µF 50mA 19207160 2866172 11794877 10741855 
200V .1µF 100mA 17177040 8404301 6040.96 6671.187 
120V .1µF 100mA 19619920 4020815 5132837 11457930 
75V .1µF 100mA 22298540 6076935 8631424 11815131 
45V .1µF 100mA 24044000 3329040 24083820 3580727 
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20V .1µF 100mA 21073680 2847513 18316350 10348991 
5V .1µF 100mA 23102640 2970523 18766881 10319693 
200V 1µF 1mA 18793092 10943162 6147310 12173124 
120V 1µF 1mA 23432200 2652928 8358164 11538802 
75V 1µF 1mA 24290700 2792264 13317231 12837114 
45V 1µF 1mA 25280940 2453704 20649991 11823469 
20V 1µF 1mA 23658000 1836036 23617220 2092379 
5V 1µF 1mA 22144520 1718994 18899720 9660354 
200V 1µF 2mA 20699980 3898524 4334663 9468002 
120V 1µF 2mA 20230880 3632078 13919999 12742644 
75V 1µF 2mA 18737640 3382171 8694742 12006978 
45V 1µF 2mA 22628000 2846161 12724938 11509633 
20V 1µF 2mA 19111600 1203094 15811693 8909142 
5V 1µF 2mA 19410980 420248.6 15200367 8516893 
200V 1µF 5mA 21580720 4707117 4966122 11093513 
120V 1µF 5mA 22167280 1746724 9295118 12729316 
75V 1µF 5mA 22242800 1914323 13531420 12436992 
45V 1µF 5mA 21287740 2183627 17813827 10096481 
20V 1µF 5mA 15547958 8614955 19870820 1965733 
5V 1µF 5mA 22983620 5708802 19283805 11611022 
200V 1µF 10mA 20869620 2340181 2412.112 1342.27 
120V 1µF 10mA 7827510 9834031 1247.771 262.3298 
75V 1µF 10mA 22572700 3568272 19743351 11496051 
45V 1µF 10mA 20972300 2493912 13190207 12057603 
20V 1µF 10mA 20448820 2940829 12162801 11234977 
5V 1µF 10mA 22473160 935866.1 18616556 10524174 
200V 1µF 20mA 22890720 4372069 5774326 12910818 
120V 1µF 20mA 22976160 3246869 4392982 9820261 
75V 1µF 20mA 18405219 10726063 10867875 14930243 
45V 1µF 20mA 19654500 1225567 16366135 9233106 
20V 1µF 20mA 15923529 8910025 15881104 8939320 
5V 1µF 20mA 19807080 5811174 15393918 10093846 
200V 1µF 50mA 20295500 1768892 4416104 9873691 
120V 1µF 50mA 20354280 7460542 5754493 12865892 
75V 1µF 50mA 20490820 3413482 7261.704 8166.807 
45V 1µF 50mA 22140700 5309857 16249662 9917794 
20V 1µF 50mA 21320500 3895169 18388141 11025947 
5V 1µF 50mA 21304600 1206842 17332062 9761126 
200V 1µF 100mA 20716840 2772424 443.5232 189.509 
120V 1µF 100mA 20636080 3326407 829.6632 296.6535 
75V 1µF 100mA 20179500 5748409 4143076 9255993 
45V 1µF 100mA 17188472 7976142 10109178 10241248 
20V 1µF 100mA 20964280 1801548 21157280 1002969 
5V 1µF 100mA 16308773 9255497 14969605 9723512 
200V 10µF 1mA 14944124 9253258 5638675 10263417 
120V 10µF 1mA 21608900 4040027 9844898 13395137 
75V 10µF 1mA 18792560 1268525 8198809 10251290 
45V 10µF 1mA 21263780 5967698 16599475 14357906 
20V 10µF 1mA 18214520 1933357 18768060 1119792 
5V 10µF 1mA 19803160 1819918 17743200 6443152 
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200V 10µF 2mA 20910080 6311669 1153687 2129351 
120V 10µF 2mA 19246560 1891773 4930991 8691508 
75V 10µF 2mA 18346738 10448299 10155861 13901490 
45V 10µF 2mA 20344900 7395168 15745965 13434574 
20V 10µF 2mA 12181010 11305004 11443064 11400528 
5V 10µF 2mA 20641720 2156390 17128759 10127915 
200V 10µF 5mA 20221480 1411898 8318.874 5921.798 
120V 10µF 5mA 15521296 8670207 4183166 9298040 
75V 10µF 5mA 11962006 11118744 4207201 8806525 
45V 10µF 5mA 24470380 4953512 10329505 14028392 
20V 10µF 5mA 18009200 10583935 18886723 11141835 
5V 10µF 5mA 21774100 2329822 17881612 10072890 
200V 10µF 10mA 21570320 3224722 1673.75 494.7733 
120V 10µF 10mA 14716858 8453589 2856.382 3497.503 
75V 10µF 10mA 15136414 8486168 7641584 10393145 
45V 10µF 10mA 18913400 2012246 8706605 11952138 
20V 10µF 10mA 20153360 1528876 16450396 9288995 
5V 10µF 10mA 16017733 9096929 11508679 10580860 
200V 10µF 20mA 15640541 8898123 1195.448 2161.881 
120V 10µF 20mA 21097100 1966878 1048.699 1506.763 
75V 10µF 20mA 15446566 5454359 3722.766 3905.171 
45V 10µF 20mA 12862048 11816030 10805362 10894943 
20V 10µF 20mA 17988250 9176021 18106621 10282063 
5V 10µF 20mA 14609116 8816261 15527111 9127104 
200V 10µF 50mA 19232240 1254804 469.6034 376.6848 
120V 10µF 50mA 16755040 5501363 4638054 10360401 
75V 10µF 50mA 11046087 8934252 15917699 10755606 
45V 10µF 50mA 23052000 2143055 13813665 12665530 
20V 10µF 50mA 22912620 4981176 16397966 9438271 
5V 10µF 50mA 18814307 10422068 18137149 10305116 
200V 10µF 100mA 16047945 9270757 9106.96 14457.08 
120V 10µF 100mA 20734580 1757133 2350.79 1696.166 
75V 10µF 100mA 13366263 10538992 4101699 9168941 
45V 10µF 100mA 20616240 1989455 546190.3 1209246 
20V 10µF 100mA 15899312 8810599 11665750 10730465 
5V 10µF 100mA 20054360 1125106 15596078 8548419 
200V 100µF 1mA 16045962 8876481 8595199 11391617 
120V 100µF 1mA 20031940 2840451 8459899 11460684 
75V 100µF 1mA 19953580 1496006 5009177 8345154 
45V 100µF 1mA 16203496 9108246 7010131 8870964 
20V 100µF 1mA 19433200 2599805 15733947 8928791 
5V 100µF 1mA 18960660 626938.8 14827644 8308685 
200V 100µF 2mA 21936080 1937055 11605860 10784904 
120V 100µF 2mA 21258440 1462071 20001.44 9669.189 
75V 100µF 2mA 19974200 2519972 26776.3 21029.48 
45V 100µF 2mA 21485000 3167253 10578221 10541473 
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20V 100µF 2mA 16743861 9471049 12086950 11071474 
5V 100µF 2mA 20047980 1808046 15355890 8692896 
200V 100µF 5mA 17908480 6455690 8369.32 9591.658 
120V 100µF 5mA 16651305 9418118 50816.65 105591 
75V 100µF 5mA 16212119 8947458 3852534 8608340 
45V 100µF 5mA 23027200 1830998 13407318 12250681 
20V 100µF 5mA 19048638 10564758 13856438 12816752 
5V 100µF 5mA 22465100 1005901 17976309 10176629 
200V 100µF 10mA 16725935 9339428 1351.688 617.5122 
120V 100µF 10mA 19293880 1741075 3567.102 2878.392 
75V 100µF 10mA 20158660 2246016 4840462 10810685 
45V 100µF 10mA 19967840 651318.5 10971675 10046403 
20V 100µF 10mA 19034940 1913898 16044595 9289515 
5V 100µF 10mA 17391259 9567888 16590098 9430666 
200V 100µF 20mA 20002280 1909702 1453.359 1592.998 
120V 100µF 20mA 20420100 1856389 11453.01 16447.72 
75V 100µF 20mA 21135140 878139.8 3882518 8675599 
45V 100µF 20mA 14914416 8247230 14454434 8418662 
20V 100µF 20mA 18914140 1620190 19083624 11419250 
5V 100µF 20mA 11259021 9783383 16165991 9267639 
200V 100µF 50mA 12347102 10866349 1573.935 836.9623 
120V 100µF 50mA 20619500 2753699 8404.433 10905.42 
75V 100µF 50mA 19121880 1846886 4615.146 4661.464 
45V 100µF 50mA 21032040 1132806 5515172 9029777 
20V 100µF 50mA 21928220 1081908 23113100 1006921 
5V 100µF 50mA 17397921 10045793 15917788 8956765 
200V 100µF 100mA 24456900 3695032 15879.99 10940.56 
120V 100µF 100mA 19739148 11206031 79145.03 153743 
75V 100µF 100mA 24158680 6739214 20566975 13311476 
45V 100µF 100mA 18929040 1974391 11774871 10799984 
20V 100µF 100mA 21178480 1223216 22027560 858598 
5V 100µF 100mA 21251200 2039318 21459100 1942155 
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Stage 3 Data Set 
Table 12 ECG Statistical Data from Holter Monitor Study 
 
Data Set LFHF1/LFHF2 mean_bpm stdev RMSSD SDNN 
FLEXsm 32200 0.115478 60.7939 20.2264 0.162078 0.145045 
AgAgClsm 32200 0.732602 60.17384 15.81995 0.136034 0.134312 
FLEXmed 32201 0.02405 56.70799 26.93959 0.162123 0.143802 
AgAgClmed 32201 1.977593 54.22242 23.63568 0.081215 0.081143 
FLEXlrg 32202 0.755144 54.79061 4.986064 0.069372 0.089745 
AgAgCllrg 32202 0.837004 54.79103 4.989303 0.069013 0.089793 
FLEXsm 32203 1.864379 90.67573 15.78291 0.226128 0.165255 
AgAgClsm 32203 2.120368 94.58032 25.55936 0.139057 0.116364 
FLEXmed 32204 1.233448 87.23204 14.89159 0.055505 0.047154 
AgAgClmed 32204 1.217927 89.0053 19.43673 0.075415 0.070167 
FLEXlrg 32205 1.422611 84.44314 9.290831 0.102009 0.083592 
AgAgCllrg 32205 1.298235 84.43318 9.262671 0.102067 0.083582 
FLEXsm 32206 0.795306 74.94703 7.540951 0.060891 0.081442 
AgAgClsm 32206 0.85582 74.94663 7.540027 0.060889 0.081415 
FLEXmed 32207 2.032206 74.10102 15.7365 0.070487 0.09281 
AgAgClmed 32207 2.554229 73.32206 13.66124 0.054126 0.078721 
FLEXlrg 32208 8.427059 73.72798 7.42193 0.068656 0.081444 
AgAgCllrg 32208 8.389069 73.72535 7.41006 0.068171 0.081272 
FLEXsm 32209 3.482458 82.23354 10.6115 0.070798 0.076561 
AgAgClsm 32209 3.546698 82.25557 10.67431 0.076084 0.078068 
FLEXmed 32210 9.733993 87.03194 29.32527 0.112407 0.083469 
AgAgClmed 32210 2.778694 91.04032 33.76334 0.127903 0.10866 
FLEXlrg 32211 3.15332 85.19336 17.7208 0.103152 0.105677 
AgAgCllrg 32211 3.067877 85.43892 18.81765 0.114578 0.11104 
FLEXsm 32212 0.240154 70.9016 14.33862 0.112198 0.103586 
AgAgClsm 32212 0.239874 70.90352 14.34177 0.112709 0.103739 
FLEXmed 32213 0.779402 68.30566 18.78853 0.113253 0.106384 
AgAgClmed 32213 0.793778 67.28251 15.17159 0.067039 0.062204 
FLEXlrg 32214 8.600545 68.11892 10.77145 0.12346 0.116721 
AgAgCllrg 32214 8.788925 67.45588 9.663989 0.120315 0.110542 
FLEXsm 32215 2.144912 79.00958 3.310359 0.0334 0.032013 
AgAgClsm 32215 2.281293 79.00843 3.297644 0.03319 0.031873 
FLEXmed 32216 0.32633 80.50483 3.405304 0.039327 0.030462 
AgAgClmed 32216 0.284591 80.50256 3.373997 0.038583 0.030217 
FLEXlrg 32217 3.70249 82.18458 3.840546 0.02525 0.03367 
AgAgCllrg 32217 3.364493 82.28119 5.207108 0.044282 0.039505 
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FLEXsm 32218 9.272487 82.15149 9.838289 0.037748 0.044353 
AgAgClsm 32218 9.972932 82.1104 9.636913 0.024489 0.041495 
FLEXmed 32219 21.43511 83.04281 4.283717 0.026555 0.036878 
AgAgClmed 32219 22.01814 83.04332 4.291414 0.026565 0.0369 
FLEXlrg 32220 69.68619 82.51175 5.756404 0.027176 0.049969 
AgAgCllrg 32220 74.80441 82.51198 5.756223 0.027367 0.05 
FLEXsm 32221 12.09203 75.52643 7.266304 0.109071 0.079121 
AgAgClsm 32221 25.20104 75.36104 6.602555 0.077836 0.063401 
FLEXmed 32222 1.08093 74.85776 11.97772 0.072124 0.063968 
AgAgClmed 32222 1.106051 74.85727 11.97643 0.072036 0.063928 
FLEXlrg 32223 62.27231 80.63327 8.819586 0.032638 0.075572 
AgAgCllrg 32223 61.01428 80.6342 8.824895 0.032913 0.075604 
FLEXsm 32224 0.851092 63.71633 34.75368 0.226807 0.204128 
AgAgClsm 32224 0.420575 64.84749 21.66034 0.271167 0.221883 
FLEXmed 32225 0.507751 58.69086 14.6728 0.161173 0.146154 
AgAgClmed 32225 0.03221 93.53589 74.85961 0.403599 0.332405 
FLEXlrg 32226 1.851071 59.17038 19.22364 0.074436 0.065634 
AgAgCllrg 32226 1.660257 59.17349 19.22796 0.075955 0.066121 
FLEXsm 32901 19.69471 68.87823 7.96708 0.080339 0.095823 
AgAgClsm 32901 20.74458 68.86074 7.914424 0.075709 0.094686 
FLEXmed 32902 52.42554 69.16672 8.327496 0.073486 0.103235 
AgAgClmed 32902 54.51254 69.16144 8.307076 0.073582 0.103228 
FLEXlrg 32903 2.926673 68.47285 8.211589 0.069475 0.079338 
AgAgCllrg 32903 2.134821 68.52478 8.539375 0.077264 0.082245 
 
